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Abstract 
This thesis investigated whether resting and/or exercise-induced interleukin-8 (IL-8) and tumor 
necrosis factor-α (TNF-α) production by antigen-stimulated polymorphonuclear neutrophils 
(PMN) would alter over a 12-day intensified training period (ITP). Ten physically active males 
completed seventeen exercise sessions in total, including: two main trials (30-min self-paced 
treadmill run (RPETR), 10 km time trial), completed before (MTPRE) and after (MTPOST) a twelve  
day ITP, and two V̇O2max tests completed before (VO2PRE) and after (VO2POST) the ITP. Blood 
samples were collected via venepuncture before and after the RPETR at MTPRE and MTPOST. 
PMN were isolated from whole blood and incubated for 18 h with lipopolysaccharide (LPS) 
antigen. IL-8 and TNF-α production by LPS-stimulated PMN was determined using enzyme-
linked immunosorbent assay (ELISA) tests. TNF-α production by LPS-stimulated PMN 
significantly elevated in response to the RPETR at MTPRE (P = 0.004) and MTPOST (P = 0.047). 
IL-8 production only significantly increased in response to the RPETR at MTPRE (P = 0.033) but 
not at MTPOST (P = 0.199). The absolute RPETR-induced increase in TNF-α and IL-8 
concentrations by LPS-stimulated PMN were lower at MTPOST compared to MTPRE. Blood PMN 
concentration increased significantly following the completion of RPETR at MTPRE (P = 0.02) 
and MTPOST (P = 0.016). Resting and RPETR-induced blood PMN concentrations did not 
significantly differ between MTPRE and MTPOST (P = 0.521).  Following the completion of the 
ITP, V̇O2max (P = 0.696) and 10 km time to completion scores (P = 0.457; d = 0.32) did not 
change. The severity of upper-respiratory tract symptoms (URTS) increased in six out of ten 
participants following the ITP. Self-reported general (P = 0.040) and sport-related (P = 0.005) 
stress scores were higher at MTPOST compared to MTPRE. The identification of increased stress 
states, more severe URTS, and decreased physical performance capacities in participants 
indicates that overreaching may have been achieved following the ITP. Reduced pro-
inflammatory cytokine production in response to acute exercise following a period of intensified 
training may predispose athletes to impaired inflammatory responses during exercise which 
may contribute to the pathogenesis of reported URTS in athletes who are overtraining. 
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Chapter 1. Introduction 
The primary aim of athletic training is to improve physical performance by using effective 
training intensities and volumes whilst incorporating an adequate amount of recovery to 
promote biological adaptation (Dick, 2007). When training load is increased without a 
corresponding increase in recovery, then athletes may experience symptoms of fatigue and 
underperformance termed overtraining (Meeusen et al., 2013). The overtraining continuum 
has been categorized into three conditions, functional overreaching (FOR), non-functional 
overreaching (NFOR), and the overtraining syndrome (OTS) (Meeusen et al., 2013). FOR is 
characterized by a short-term reduction in physical performance capacity lasting days to 
weeks which may lead to a super-compensatory increase in physical performance capacity. 
In contrast, NFOR is characterized by the stagnation of physical performance capacity lasting 
weeks to months which can ultimately be restored after a sufficient recovery period (Meeusen 
et al., 2013). The OTS is thought to occur at the end of this continuum following a prolonged 
imbalance between training and recovery. This syndrome is defined by a long-term decrement 
in physical performance capacity that can last from several months to years, with some cases 
reporting no recovery at all (Dupuy et al., 2010; Meeusen et al., 2013).  
Besides the decline in physical performance capacity, athletes who have reportedly developed 
NFOR or the OTS are known to experience an increased susceptibility to upper-respiratory 
tract symptoms (URTS). This increased susceptibility to URTS is associated with the 
development of immune impairments that arise following periods of intensified training (Peters 
and Bateman, 1983; Neiman et al., 1990; Verde et al., 1992; Gomez-Merino et al. 2005; 
Morgado et al., 2012). It is yet to be determined however which particular immune impairment, 
or the effect of multiple impairments, may lead to the pathogenesis of reported URTS in 
athletes.  
Markers of biological responses have been proposed as potential tools to highlight the onset 
of overtraining, thus helping to prevent such states in the future (Meeusen et al., 2013). No 
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reliable marker however has currently been established, although many have been suggested. 
Decrements to physical performance capacity have been frequently used to identify states of 
fatigue and overtraining (Jeukendrup et al., 1992; Halson et al., 2002; Dupuy et al., 2010). 
Performance capacity can however be highly influenced by other variables such as 
psychosocial stressors, inadequate nutritional intake, and the development of illness (Morgan 
et al., 1987; Hooper and MacKinnon, 1995). Reduced heart rate (HR) responses to 
submaximal and maximal exercise have also been reported in athletes clinically diagnosed 
with NFOR or the OTS (Costill et al., 1988; Lehmann et al., 1991; Jeukendrup et al., 1992; 
Hedelin et al., 2000). Such  responses however are influenced by individuality and external 
factors that limits its use as a sensitive marker.  
Polymorphonuclear neutrophils (PMN) are powerful effector leukocytes that are the earliest 
and most abundant cell type mobilized during the inflammatory response against antigens that 
can cause infection or tissue damage (Abbas et al., 2014). PMN are enforced with microbicidal 
properties that are activated to support the clearance of such antigens (Abbas et al., 2014). 
The microbicidal activity of PMN is a result of 3 primary functions; (1) the uptake of antigens 
within vacuoles (phagosomes) which fuse with degrative enzymes (lysosomes) to destroy 
captured antigens (termed phagocytosis); (2) the generation of reactive oxygen species (ROS) 
by increasing intracellular O2 consumption (via respiratory burst) which aids in the clearance 
of phagosome-bound and extracellular antigens; (3) the translocation of granules containing 
antimicrobial enzymes to the PMN membrane where they are released into the extracellular 
space (via degranulation) (Mayadas et al., 2012).  
The microbicidal function of PMN has been reported to decrease following short-to-moderate 
(~ 2-5 weeks) intensified training periods (ITP) (Blannin et al., 1997; Robson et al., 1999a; 
Yaegaki et al., 2007; Robson-Ansley et al., 2007; Leal, 2017). The degranulation response by 
antigen-stimulated PMN has been reported to decrease by 20%, 26% and 30% following a 
two-week period of intense interval training in highly-trained runners (Robson et al., 1999a), a 
two-week period of intense interval training in male triathletes (Robson-Ansley et al., 2007), 
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and a 5-week ITP in previously sedentary individuals (Blannin et al., 1997), respectively. 
Phagocytic activity by antigen-stimulated PMN has also been reported to decrease by 47% 
and 30% in males who had completed a 12-day ITP where training load was increased by 
147% (Leal, 2017) and in female judoists who had completed a 20-day period of intense 
running, judo and weightlifting training (Yaegaki et al., 2007), respectively. A decreased PMN 
function has therefore been regarded as a potential biological marker in highlighting states of 
overtraining in athletes (Gleeson, 2002; Yaegaki et al., 2008). 
Not all PMN functions have been studied in overtrained individuals. It is well documented that 
PMN synthesize and release a wide range of pro- and anti-inflammatory cytokines and are 
therefore significant mediators of the body’s inflammatory response to antigen challenge 
(Cassatella, 1999; Tecchio et al., 2014). Cytokines are a category of signalling proteins that 
activate and control the mechanisms responsible for inflammation (Coico, 2015). Inflammation 
is a protective response to regulate antigen clearance and the remodelling process of 
damaged tissue (Coico, 2015). The cytokines interleukin-8 (IL-8) and tumor necrosis factor 
alpha (TNF-α) are classified as pro-inflammatory cytokines and are produced by PMN once 
stimulated by antigen challenge such as the endotoxin lipopolysaccharide (LPS) (Cassatella, 
1999). Due to the increasing evidence that PMN microbicidal function becomes impaired 
following an ITP, it is possible that PMN ability to produce pro-inflammatory cytokines may 
also become impaired. A decreased production of pro-inflammatory cytokines by PMN 
following an ITP may reduce the effectiveness of the inflammatory response in successfully 
clearing  antigen challenge from the body. Ultimately, this may be one of several immune 
impairments that occur after an ITP responsible for the pathogenesis of reported URTS in 
athletes who are overtrained. 
Pro-inflammatory cytokine production by antigen-stimulated PMN may also play an important 
role in the acquisition of inflammatory-derived symptoms associated with states of overtraining 
(Fry et al., 1991). The cytokine hypothesis developed by Smith et al. (2000) suggests that 
muscle and connective tissue microtrauma caused by repeated exercise with limited recovery 
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triggers the release and accumulation of pro-inflammatory cytokines that develops a state of 
acute systemic inflammation. A state of acute systemic inflammation may consequently trigger 
neuroinflammation (Dantzer et al., 2008) through blood-brain communication mechanisms 
that can evoke the development of sickness behaviours such as anorexigenic behaviour 
(Romanatto et al., 2007), chronic fatigue (Morris et al. 2015), mood decline (Miller and Raison, 
2016) and an increased sensitivity to pain (Zhang and An, 2007). Because PMN play a 
significant role in mediating the inflammatory response, their ability to produce pro-
inflammatory cytokines may contribute to the acquisition of such sickness behaviours that are 
associated with overtraining. It is not currently known if pro-inflammatory cytokine production 
by antigen-stimulated PMN is elevated by a single bout of exercise, therefore one aim of this 
study was to measure the production of IL-8 and TNF-α by antigen-stimulated PMN in 
response to a 30-minute high-intensity, self-paced treadmill run.  
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Chapter 2. Literature Review 
2.1 Overreaching and the Overtraining Syndrome 
2.1.1 The General Adaptation Syndrome 
In 1936, Hans Selye developed the concept of the general adaptation syndrome (GAS). The 
GAS highlights how an organism can adapt once it is exposed to a novel, potentially damaging 
stimulus (Selye, 1936). Selye detailed two main stages of GAS which indicate the body’s ability 
to overcome and adapt to novel stressors. The first stage is known as the ‘alarm’ stage. The 
alarm stage occurs 6-48 hours after the initial contact with the novel stress and will lead to a 
rapid decline to the body’s physical and biological capacity. The second state is the 
‘resistance’ stage which occurs ~48 hours after contact with the novel stress. The body begins 
developing a resistance against the stress by activating a series of defence mechanisms to 
restore homeostasis. Selye identified enlarged adrenal glands and the reduction of oedema 
size in his participants (Selye 1938) – we would now identify this as the actions of hormones 
(i.e. cortisol) and the immune system (lymphatic system) working to restore homeostasis 
during this stage (Desborough, 2000; Mortimer and Levick, 2004). It is also during the latter 
stages of resistance against the stimuli where it is believed that if the defensive mechanisms 
build such a resistance against the stimuli, then the individual would succumb to a full recovery 
by physiological adaptation. If the defensive mechanisms against the stimuli are too weak, or 
the potency of the stimuli is too severe, then a 3rd stage, known as the exhaustion stage, may 
be experienced (Selye, 1936). During this exhaustion phase, it is thought that the body would 
eventually lose its resistance against the stimuli and thus would begin to exhibit negative 
symptoms which would have been observed prior to the resistance stage (Selye, 1936). An 
overview of the GAS can be seen in Figure 2.1.  
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Figure 2.1:  A schematic overview of the general adaptation syndrome (GAS) (Selye, 1936). 
2.1.2  Adaptation to Exercise Stress 
In order to improve physical performance capacity, the body must build a resistance and adapt 
to the novel stress imposed upon the body during exercise (Whyte, 2006). To achieve such 
adaptations, training load and recovery must be appropriately monitored to prevent an 
overload of stress which would cause a loss of adaptation and subsequently cause the 
development of maladaptation (Selye, 1950). Periodization is a method to help develop an 
athlete’s peak performance by planning cycles of training using variations of training methods, 
intensities and frequencies to promote positive adaptations and to help to manage fatigue 
appropriately (Bompa and Haff, 2009). During preparation cycles of periodization, whereby an 
athlete would undergo an ITP with limited recovery (Bompa and Haff, 2009), the planned 
increase in training stress would lead to the initial ‘alarm’ stage – in line with Selye’s GAS 
theory (Selye, 1936). Following this period, the exercise stimuli would have caused a 
noticeable decrease to physical performance capacity by reducing various physiological and 
mechanical functions of the body. This increase in training stress, the imbalance of recovery 
periods and a subsequent decrease to physical performance capacity is otherwise known as 
overtraining (Meeusen et al., 2013).  
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2.1.3 Overreaching 
Overreaching has been defined by a joint consensus statement from the European College of 
Sport Science (ECSS) and the American College of Sports Medicine (ACSM) (2013) by 
Meeusen and colleagues (Meeusen et al., 2013). This document defined overreaching as: 
 An accumulation of training and/or non-training stress that results in short-term 
decrements to physical performance capacity. A decrease to performance capacity can 
be seen with or without any signs or symptoms of performance-related maladaptation.  
There are two forms of overreaching, FOR and NFOR (Meeusen et al., 2013). The 
differentiation of these states was to provide clarity to the definition by emphasizing that 
overreaching could develop either positive or negative effects to an athlete’s physical 
performance capacity depending on how well it is controlled by the athlete or coach (Meeusen 
et al., 2013). The statement by Meeusen and colleagues (2013) however did not establish the 
longevity of each stage and when each stage would transition along the ‘overtraining 
continuum’, i.e. when does FOR transition into NFOR.  
2.1.4 Functional and Non-functional Overreaching  
In line with Selye’s GAS theory (Selye, 1936), intensified periods of training with insufficient 
rest periods over a short duration will impose a great stress upon the human body, causing a 
decline in the body’s physical and biological capacity. This ultimately leads to a decline in 
physical performance capacity (Dick, 2007). With the application of appropriate recovery 
periods however, a ‘super-compensatory’ effect may occur whereby physical performance 
capacity can elevate to a level above that achieved after a period of regular periodized training 
(Dick, 2007). This adaptation to exercise training is known as FOR (Meeusen et al., 2013). 
The benefits of FOR in relation to physical performance mean that coaches often use ITP in 
the form of training camps to improve their athlete’s performance prior to competition (Thiel et 
al., 2011). The recovery time for super-compensation to occur is essential. If a lack of recovery 
is implemented before a new overload of exercise stress is given, then a greater imbalance 
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between training and recovery will occur. A prolonged imbalance between training and 
recovery will ultimately see athlete’s progress along the ‘overtraining continuum’ to a state of 
NFOR and eventually OTS. Such short-term periods of FOR are generally not accompanied 
by the presence of severe physiological or psychological symptoms (Birrer et al., 2013). It is 
possible for athletes to recover from FOR within a 2 week period (Halson et al., 2002).  
If intensified training continues without the application of appropriate recovery periods, NFOR 
may occur (Meeusen et al., 2013). The only distinction between states of FOR and NFOR is 
the duration of time it takes for recovery to occur. Recovery from NFOR can occur and physical 
performance can return to baseline levels, albeit not always to the same performance capacity, 
however it may take athletes several weeks to months of rest for this to occur (Halson et al., 
2002). The super-compensatory effect observed following a state of FOR will not occur 
following a state of NFOR (Meeusen et al., 2013). If the development of NFOR is not identified 
by either athlete or coach, then it may progress in severity, leading to the OTS.  
2.1.5 The Overtraining Syndrome  
The OTS has been classified by the ECSS and ACSM (2013) as: 
An accumulation of training and/or non-training stress that results in a long-term 
decrease to physical performance levels. Restoration of physical performance capacity 
may take from several months to years, and in severe cases,  may never occur.  
The only objective difference between NFOR and the OTS is the amount of time it takes for a 
full recovery to occur. A diagnosis of either condition can thus only be made retrospectively 
once the time frame of maladaptation can be observed (Sims, 2001; Meeusen et al., 2013). A 
possible presentation of the different stages of FOR, NFOR and the OTS can be found in 
Table 2.1.   
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Table 2.1: The theorised progression through the different stages of FOR, NFOR and the 
OTS. Adapted from Bompa and Haff (2009), and Meeusen et al. (2013).  
 
Out of 376 young athletes competing at club-international level and spanning across 19 
different sports, 29% had experienced NFOR or OTS at least once in their life (Matos et al., 
2011). Similar prevalence percentages of NFOR and OTS have been reported in adult 
athletes, with 37% of elite Swedish athletes (Kenttã et al., 2001), ranging across 26 sports, 
and 35% of competitive swimmers (Raglin et al., 2000) having experienced symptoms of 
NFOR or OTS at least once within their life.  
2.1.6 Symptoms of Overtraining 
For clarity, the verb ‘overtraining’ describes the process of over-training through the continuum 
of FOR, NFOR and the OTS. The action of overtraining is best characterized by a decreased 
physical performance capacity (Meeusen et al., 2013). This however appears to be the only 
clear measure. There is no definitive list of overtraining symptoms as they appear to be relative 
from person to person. Fry et al. (1991) compiled a list of symptoms based on their appearance 
in literature. Symptoms were subcategorized as physiological performance impairments, 
psychological/information processing impairments, immunological impairments, and 
biochemical impairments. Robson-Ansley and Costa (2014) compiled this list down to 6 
primary symptoms which may be more commonly reported. These symptoms were: 
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1. Increased fatigue during exercise 
2. Underperformance with an inability to increase the pace at the end of a race 
3. Increased fatigue and sleepiness during the day 
4. Increased URTS 
5. Reduced sleep quality 
6. Slow wound healing and muscle soreness 
2.1.7 Markers to Detect Overtraining 
Identifying a marker or markers to detect overtraining would be beneficial to athletes and 
coaches as it would allow for the continual monitoring of training stress which would help 
reduce the incidence of NFOR and the OTS. One commonality often shared between athletes 
who are overtraining is the decline in physical performance capacity (Jeukendrup et al., 1992;  
Halson et al., 2002; Dupuy et al., 2010). It has therefore been proposed that the use of physical 
performance tests such as time trials (TT) may be useful when attempting to detect the onset 
of NFOR and the OTS (Schmikli et al., 2011). Indeed, both Jeukendrup et al. (1992) and 
Halson et al. (2002) reported significantly slower time to completion scores in response to 
simulated TT tests when athletes had reportedly developed a state of overreaching. There are 
however issues with using performance markers to identify overtraining. For example, 
performance decrements may result from psychosocial stressors, inadequate nutritional 
intake, and the development of illness (Morgan et al., 1987; Hooper and MacKinnon, 1995) 
thus reducing its reliability as a marker. 
For the purpose of this present study, the following markers were used in an attempt to detect 
whether or not participants were overreached by the end of the ITP: (1) Time to completion of 
a 10 km time trial (2) the development or increased severity of URTS in participants (3) 
Increased perception of stress levels reported by participants. 
Elevated training and/or non-training stress with insufficient recovery has been reported to 
alter many biological functions such as the immune system (Gleeson and Williams, 2013). A 
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measure of immune function at rest or in response to an exercise test may therefore be a more 
sensitive marker to highlight a state of overtraining in athletes compared to the aforementioned 
performance markers.  
2.1.8 Immune Markers to Detect Overtraining 
The immune system appears to be sensitive to changes in exercise stress and therefore many 
immune parameters have been reported to alter following an ITP (Gleeson and Williams, 
2013). These changes to immune function could therefore be used as potential biological 
markers to highlight whether an athlete is overtraining or not. Many of the previously reported 
immune alterations following an ITP which have been suggested as potential biological 
markers within the literature can be found in the forthcoming paragraph.  
Secretory immunoglobin A (slgA) is the primary antibody found in mucous membranes and 
can be an indicator of mucosal immunity (McGhee et al., 1992). SlgA concentration at rest 
has been documented to decrease following both short- and long-term ITP (Mackinnon, 1996; 
Fahlman and Engels, 2005; Gleeson, 2006a; Bishop and Gleeson, 2009; Gleeson et al., 
2012). The total number and function of lymphocytes – a  subtype of leukocyte which 
comprises the highly-specific adaptive immune response against antigen challenge – has  
been reported to decrease (Walsh and Oliver, 2016). Circulating numbers of natural killer cells 
and their cytotoxic activity has been reported to decrease over a 7-month training season in 
elite swimmers (Gleeson et al., 1995) and over a 3-week intensive military training course 
(Gomez-Merino et al., 2005).  CD4+ T cells and their ability to produce the cytokine interferon-
gamma have been reported to decrease following 6 months of intensive cycling training (Baj 
et al., 1994) and a 6-day period of intensified training (Lancaster et al., 2004). In addition, the 
T cell expression of the leukocyte membrane antigen CD45RO was reported to be higher in 
athletes who were clinically diagnosed with OTS. Reductions in B cell immunoglobin synthesis 
have been documented in OTS athletes (Verde et al., 1992).  Collectively, these findings 
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suggest that the adaptive immune response against antigen challenge is dysregulated in 
overtrained athletes and may be beneficial in highlighting overtraining in athletes.  
Gleeson (2002) suggested that measures of CD45RO+ T cells (Gabriel et al., 1998), salivary 
IgA concentrations (MacKinnon, 1996) and PMN function (Blannin et al., 1997; Robson et al., 
1999a) could be used to indicate an impending state of OTS in athletes. Yaegaki et al. (2008) 
suggested that PMN function could be a viable predictor of overtraining in athletes as they 
reported an exercise-induced reduction in ROS production by antigen-stimulated PMN 
following a 7-day intensive (two-fold increase in training load) judo training camp. Recent 
research on PMN function following a period of intensified training has examined their primary 
microbicidal functions including antigen-stimulated phagocytic activity, ROS production and 
degranulation response (Blannin et al., 1997; Robson et al., 1999a; Yaegaki et al., 2007; 
Robson-Ansley et al., 2007; Leal, 2017). If PMN function is to be used as a biological marker 
to detect the onset of NFOR and the OTS, it is important to investigate how other PMN 
functions are influenced following a period of intensified training. At present, no research has 
been undertaken to examine whether the release of pro-inflammatory cytokines by PMN is 
affected by a period of intensified training. This thesis will therefore examine whether a 12-
day period of intensified training alters pro-inflammatory cytokine production by antigen-
stimulated PMN.  
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2.2 The Immune System 
2.2.1 Immunity 
The environment is populated by an array of foreign agents such as bacteria, viruses, fungi, 
protozoa, prions and parasitic organisms, allergens, pollutants and other toxic substances 
which trigger immune responses in the human body (Alberts et al., 2002). Triggers of immune 
responses are broadly known as antigens. Foreign antigens can enter the body via inhalation, 
ingestion, and through physical boundaries such as the skin and mucous membranes 
(Janeway and Medzhitov, 2002). The human body can also be exposed to self-antigens that 
originate within the body, triggering autoreactive responses that can result in cell death or 
damage (Anders and Schaefer, 2014). To counteract these threats, the human body uses the 
immune system to distinguish healthy host cells from diseased, dying or dead host cells, or 
foreign antigens (Alberts et al., 2002). The immune system minimizes autoimmunity and 
allergy, whilst being able to eliminate malignant host cells and foreign antigens from the body. 
For such protective mechanisms to work efficiently, the immune system is reliant on the 
detection of distinct structural features upon antigens and diseased, dying or diseased cells to 
distinguish them apart from healthy cells (Mogensen, 2009). Recognition of such structures 
allows the complex workings of the immune system to attack abnormal host cells and foreign 
antigens without damaging healthy host cells (Janeway and Medzhitov, 2002). The immune 
system works through a cascade of pathways controlled by host organs, tissues, cells and 
proteins to detect and eliminate these abnormal cells and pathogens which may subsequently 
develop illness and disease within the body (Janeway, 2001). 
2.2.2 The Innate Immune System  
The innate immune system is comprised of cellular and chemical components which represent 
the immediate, non-specific immune response to antigen challenge within the body (Lydyard, 
2004). The main goal of the innate immune system is to act immediately in response to 
antigens so that infection or prolonged tissue damage does not occur (Lydyard, 2004). The 
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physical boundaries of the human body such as the mucous membranes and the epithelial 
tissue which lines the skin, pulmonary system and gut, as well as chemical components such 
as sebum, saliva and gastric acid, pose as the first line of defence against foreign antigens 
(Clark and Kupper, 2005). Leukocytes such as dendritic cells, monocytes, macrophages, 
granulocytes (which includes PMN, eosinophils, basophils) and natural killer cells, as well as 
soluble components like complement proteins and cytokines are the second line of defence 
against both foreign and self-antigens (Clark and Kupper, 2005). 
An array of non-specific antigen receptors located intercellularly or upon cell membranes 
permit these leukocytes to recognize and interact with many antigens (Turvey and Broide, 
2010). Non-specific receptors called pattern-recognition receptors (PRR) target pathogen-
associated molecular patterns (PAMP) such as the endotoxin LPS  (Thompson et al., 2011). 
One of the most abundant groups of PRR is the Toll-like receptor (TLR) family which can 
interact with PAMP to initiate immune and inflammatory responses (Medzhitov, 2007). PRR 
also play an important role in the surveillance of tissue damage (Santoni et al., 2015). PRR 
including some TLR recognise self-antigens known as damage-associated molecular patterns 
(DAMP) that are released following cellular damage (Takeuchi and Akira, 2010). DAMP 
include intracellular heat shock proteins, high mobility group box-1 proteins, uric acid, 
mitochondrial DNA and serum amyloid A (Schaefer, 2014).  
2.2.3 Neutrophils 
PMN are large (12-15 µm in diameter) leukocytes which are characterized by the distinct 
‘lobed’ shape of their nucleus, hence the ‘polymorphonuclear’ description (Abbas et al., 2014). 
PMN are also classified as granulocytes as they possess highly degradative granules known 
as azurophilic and specific granules within their cytoplasm (Abbas et al., 2014). The normal 
healthy range of PMN in circulation is thought to be between 2 - 7.5 x 109 cells.L-1 which 
constitutes to 40-80% of all circulating leukocytes (Gargani, 2012). Rises in circulating PMN 
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numbers is clinically referred to as neutrophilia whereas a decline is known as neutropenia 
(Gargani, 2012).  
The development of PMN occurs in bone marrow from haematopoietic stem cells (Delves and 
Roitt, 1999). The differentiation process from immature stem cell to mature PMN may take up 
to ~13 days based on in vivo radiolabelling studies in humans (Patt and Maloney, 1964). The 
production of PMN can be triggered by various stimulants such as the cytokine granulocyte-
colony stimulating factor (Abbas, et al., 2014).  
Inactive PMN will circulate throughout the bloodstream until activated by chemoattractants 
that diffuse from infected or damaged tissue. Chemoattractants such as IL-8, complement 
protein C5a, and bacterial products such as formylated methionine-leucine-phenylalanine 
permit PMN to move towards the highest concentration of chemoattractant, thus mobilizing 
them into tissue which is infected or damaged (Borresgaard, 2010). PMN are released from 
bone marrow at a rate of 1011 per day (Furze and Rankin, 2008), this large-scale influx of PMN 
into the blood is equally matched by their short-life span which is thought to last for less than 
24 hours (McCracken and Allen, 2014). This short life cycle is thought to be a protective 
mechanism to prevent the cytotoxic nature of PMN from causing harm to healthy cells 
(McCracken and Allen, 2014).  
PMN possess microbicidal functions that aid in the clearance of antigens and cell debris. Such 
functions are phagocytosis, the production of ROS, degranulation, and the formation of 
extracellular traps (Kobayashi and DeLeo, 2009). To prime PMN, they must first recognize 
PAMP or DAMP using PRR such as the endocytic Dectin-1 and TREM-1 receptors, or the cell-
surface TLR (Mayadas et al., 2014). PMN also express Fc receptors and complement 
receptors that recognize opsonized antigens (Mayadas et al., 2014). 
After the body is exposed to infectious or injurious stimuli, PMN are mobilized immediately into 
the tissue where they can recognize PAMP or DAMP using particular PRR (Prince et al., 
2011). Interaction with a particular molecular pattern causes the PMN cell membrane to 
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undergo a conformational change whereby the cell membrane protrudes and surrounds the 
antigen within a vacuole known as a phagosome (Alberts, 2002). The phagosome and the 
endocytosed antigen can be broken down by fusing with lysosomes which contain lysozyme 
and acid hydrolases (Alberts, 2002). This process is known as phagocytosis (Alberts, 2002). 
Additionally, an NADPH oxidase complex can form upon the phagosome membrane. This 
reaction produces ROS such as superoxide, hypochlorite, hydrogen peroxide and nitric oxide 
(Mayadas et al., 2012). The production of ROS occurs when there is a transient rise in O2 
consumption by the PMN known as the respiratory burst (Dahlgreen and Karlsson, 1999). The 
respiratory burst permits for the rapid release of ROS from the PMN upon the phagosome and 
also into the extracellular space (Dahlgreen and Karlsson, 1999).  
Degranulation is another important function of PMN, whereby azurophilic and specific 
granules are activated within the PMN cytoplasm (Lacy, 2006). These cytotoxic granules can 
translocate to either the cell membrane or the phagosome membrane to be released via 
exocytosis into the extracellular space or into the phagosome, respectively. Extracellular traps, 
containing chromatin and bactericidal proteins, can also be released from PMN into the 
extracellular space where they can immobilize and destroy antigens (Kaplan and Radic, 2012). 
PMN also contribute to the mediation of immune and inflammatory processes through the 
release of cytokines, due to the relevance of this function to the present study rationale, this 
shall be covered more in-depth in Chapter 2.2.6.  
2.2.4 Inflammation 
Inflammation is a fundamental protective mechanism in response to antigens that may cause 
infection or tissue damage (Coico, 2015). The primary aim of inflammation is to restore 
homeostasis by clearing the presence of antigens and mediating the remodelling process of 
damaged vascular and skeletal tissue (Coico, 2015). An inflammatory response is classified 
as either acute or chronic in nature. Acute inflammation is known as the non-specific, 
immediate response to antigen challenge and is mediated by the movement of primarily PMN 
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into tissue, followed by a secondary wave of monocytes which evolve into inflammatory 
macrophages (Freire and Van Dyke, 2013). Acute inflammation is first characterized by PMN 
adherence to blood vessel walls through intracellular adhesion molecules (ICAM) (Muller, 
2013). PMN can then transmigrate across  the vascular endothelial lining and into the inflamed 
or infected tissue in order to engulf infiltrated pathogens (Muller, 2013). The process of 
transmigration is primarily mediated by a chemotactic gradient. The cytokines IL-1β and IL-8 
are two known chemoattractants that are released by cells at the inflammatory loci to form a 
chemotactic gradient in order to attract PMN to this vulnerable site. This process can also be 
accelerated by the production of TNF-α at the inflammatory loci which can upregulate ICAM 
upon endothelial cells, thus permitting more PMN to adhere to the blood vessel wall and 
subsequently transmigrate.  
Chronic inflammation is defined by a prolonged and progressive state of inflammation that 
leads to a raise in circulating (systemic) levels of pro-inflammatory cytokines and a shift in 
leukocytes present at the site of infection or injury (Coico, 2015). A hallmark sign of chronic 
inflammation is the shift from non-specific neutrophils that encompass the acute inflammatory 
response to highly-specific lymphocytes and macrophages (Allison et al., 1978). Chronic 
inflammation can evoke severe tissue damage and may lead to the pathogenesis of many 
inflammatory diseases such as stroke, chronic respiratory diseases, diabetes, cancers, and 
heart disorders (Coleman and Tsongalis, 2018).  
The physical manifestation of inflammation is characterised by the development of swelling, 
redness, heat, loss of function and pain (Coico, 2015). The natural resolution of inflammation 
can occur through the transcriptional activation of anti-inflammatory cytokines which control 
the inflammatory response (Opal and DePalo, 2000). Anti-inflammatory cytokines may 
upregulate specific pro-inflammatory cytokine inhibitors and downregulate pro-inflammatory 
cytokine receptors that activate cellular inflammatory responses (Opal and DePalo, 2000).  
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2.2.5 Cytokines 
Cytokines are low-molecular weight chemical messenger proteins that are locally produced at 
low concentrations by nucleated cells (Dinarello, 2007). Leukocytes are considered the 
primary producers of cytokines in order to regulate immune and inflammatory responses 
(Coico, 2015). Cytokines interact with cells through receptor signalling to regulate cellular 
activation, growth, proliferation, apoptosis and chemotaxis (Abbas et al., 2014). Cytokines are 
therefore considered the main intercellular signalling proteins of the immune system (Abbas 
et al., 2014). Cytokines are loosely categorized based on structure and function (Coico, 2015). 
Cytokines that attract leukocytes to areas of infection or injury are otherwise known as 
chemokines (Gargani, 2012). Broad families of cytokines exist such as the interleukins, 
colony-stimulating factors, interferons and TNF families (Tisoncick et al., 2012). Many types 
of cytokines have been reported to have either pro- or anti-inflammatory signalling effects. For 
example, the cytokines TNF-α and IL-8 are responsible for upregulating inflammatory 
mechanisms (Bickel, 1998; Walsh, 2013), whereas IL-10 has been reported to inhibit the 
inflammatory response (Couper et al., 2006). Cytokines can interact in an autocrine (same 
cell), paracrine (close proximity) and endocrine (long distance) fashion, therefore gaining their 
name as the ‘hormones of the immune system’ (Dinarello, 2007).  
2.2.6 Tumor Necrosis Factor-α Role in Inflammation 
TNF-α is a potent mediator of inflammation, acting to mobilize leukocytes, particularly 
phagocytic cells, to infected or injured tissue (Walsh, 2013). In turn, the infiltration of 
leukocytes will result in an improved host defence against antigen challenge (Coico and 
Sunshine, 2015). This process is mediated by TNF-α ability to increase vascular permeability, 
to upregulate ICAM on endothelial cells, and to induce vasodilation (Johns and Webb, 1998; 
Hoffman et al., 2002) 
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In addition, TNF-α can signal the release of cytokines such as IL-1, IL-6, IL-8 and colony-
stimulating factors from cells which help to potentiate inflammatory responses to clear foreign 
or self-antigens and to regulate other important immune responses (Maini et al., 1995).  
Excessive production of TNF-α is implicated in the pathogenesis of many illnesses and 
diseases such as sepsis, cachexia, irritable bowel disease, rheumatoid arthritis and some 
forms of cancers (Tracey and Cerami, 1994; Blandizzi et al., 1991). Astrocytes found within 
the brain (Chang and Benveniste, 1990), as well as PMN (Dubravec et al., 1990; Streiter et 
al., 1990; Bazzoni et al., 1991), monocytes (Yao et al., 1997), T cells (Von Fliedner et al, 1992)  
and natural killer cells (Balboa et al., 1992) can all produce TNF-α.  
2.2.7 Interleukin-8 Role in Inflammation 
IL-8 is a chemokine which mediates pro-inflammatory activities (Bickel, 1998) and is produced 
by epithelial cells, fibroblasts, endothelial cells, macrophages, lymphocytes, mast cells and 
PMN (Bickel, 1998). This pro-inflammatory cytokine acts as a chemoattractant to mediate the 
mobilization of leukocytes such as T cells,  basophils and in particular, PMN (Cassatella, 
1999), to sites of injury or infection (Russo et al., 2014). Elevated IL-8 concentrations within 
the blood has been shown to upregulate PMN migration into tissue by upregulating the 
formation of  ICAM upon vascular endothelial cells to ensure more PMN are able to 
transmigrate across the vascular endothelium and into potentially damaged or infected tissue 
(Bickel, 1993). IL-8 is therefore primarily responsible for the large recruitment of PMN during 
the earliest phases of acute inflammation (Baggiolini et al., 1994). 
The production of IL-8 from leukocytes can also trigger the stimulation of histamine production 
from basophils which increases vascular permeability, allowing a greater passage of 
leukocytes to the site of infection or injury (Koch et al., 1992). In addition, IL-8 production will 
stimulate the formation of new blood vessels via angiogenesis, thus maximising the delivery 
of circulating leukocytes to inflamed tissue (Koch et al., 1992).  
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2.2.8 Cytokine Production by Neutrophils 
PMN are an important source of cytokine production when activated by antigen challenge 
(Cassatella, 1999). It was initially thought that PMN were limited to only producing IL-8 
(Altstaedt et al., 1996), however advances in research have demonstrated that PMN are able 
to express and release a wide variety of pro- and anti-inflammatory cytokines (Tecchio et al., 
2014). The fact that PMN are the immediate and most abundant responders to antigen 
challenge, and will outnumber other cytokine-producing leukocytes within tissue during the 
earliest phases of acute inflammation (McCracken and Allen, 2014) highlights the importance 
pro-inflammatory cytokine production by PMN has in mediating the immediate inflammatory 
response.  
Cytokine production by PMN will occur following ligand-receptor signalling with antigens such 
as PAMP or DAMP (Cassatella, 1999; Tecchio et al., 2014). A range of PMN receptors have 
been reported to stimulate the production of cytokines following ligand-receptor signalling such 
as colony stimulating factor receptors, TLR, Fc receptors and complement receptors 
(Cassatella, 1999). An endotoxin known as LPS which can be located on the cell membrane 
of gram-negative bacteria is frequently used in vitro to stimulate the production of cytokines 
by PMN as it can bind to TLR4 which is abundant upon the PMN cell membrane (Prince et al., 
2011). The binding of LPS-TLR4 upon the cell membrane initiates the movement of the 
intracellular NF-kB transcription factor to the PMN nucleus where it can bind to specific DNA 
sequences. This subsequently leads to the transcription and translation of DNA which will 
conclude with the  protein expression of pro-inflammatory cytokines such as IL-1β, IL-6,  IL-8 
and TNF-α (Djeu et al., 1990; Dubravec et al., 1990; Streiter et al., 1990; Bazzoni et al., 1991; 
Means et al., 2000).   
PMN can also store ‘preformed’ cytokines such as IL-8 within their cytoplasm (Pellmé et al., 
2006). The exact location of storage for these preformed cytokines is uncertain however it is 
likely to be in specialised intracellular vesicles, granules or lysosomes.  
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2.3 Exercise and Neutrophils 
2.3.1 Acute Exercise and Neutrophils 
Acute exercise has been reported to alter the concentration and function of circulating PMN 
(Gleeson, 2006b). The general consensus is that neutrophilia occurs immediately and 
transiently during acute exercise (Pyne, 1994). It appears PMN concentration may exhibit a 
biphasic response to exercise whereby a transient increase during exercise is followed by a 
decline to resting values 30-60 minutes post-exercise. A delayed neutrophilia response may 
also occur 2-4 hours post-exercise (Mills et al., 2000). Neutrophilia appears to occur in an 
intensity-dependant fashion (Neiman et al., 1994) as acute bouts of low-intensity exercise 
evoke small to no changes (Saito et al., 2003; Neves et al., 2015) in PMN mobilization whereas 
high-intensity to exhaustive exercise can elicit significant increments (Field et al., 1991; 
Neiman et al., 1994; Quindry et al., 2003). Previous studies have reported that high-intensity 
to exhaustive exercise can provoke a functional change in PMN such as a modest decrease 
to in vitro antigen-stimulated degranulation response and oxidative burst capacity (Robson et 
al., 1999b).  
Exercise-induced neutrophilia may result from a corresponding rise in immunoregulatory 
glucocorticoids such as cortisol which are produced through the activation of the 
hypothalamic-pituitary-adrenocortical axis (McMurray and Hackney, 2000) in response to 
high-intensity exercise (Verde et al., 1992; Gray et al., 1993; VanBruggen et al., 2011; Hough 
et al., 2011; Hough et al., 2013). Elevated concentrations of circulating cortisol can directly 
bind to cytosolic glucocorticoid receptors and decrease the number of ICAM upon PMN, thus 
inhibiting PMN mobilization into tissue (Tessier et al., 1996; Cavalcanti et al., 2007). Likewise, 
cortisol increases the production of granulocyte-colony stimulating factor from cells which 
upregulates the production of PMN from bone marrow reserves (Cavalcanti et al., 2006). PMN 
apoptosis can also be inhibited following cortisol infusion, resulting in a longer life span in 
circulation (Liles, et al., 1995).  
23 
 
In contrast, exercise-induced neutrophilia may be modulated by the rise of cytokines such as 
granulocyte-macrophage colony-stimulating factor, TNF-α and leukotriene B4 (Shephard, 
2003) which have been reported to similarly downregulate the expression of ICAM on 
endothelial cells (Griffin et al., 1990).  
2.3.2 Chronic Exercise and Neutrophils 
An ITP lasting 2 – 5 weeks can significantly decrease the  phagocytic function of PMN 
(Yaegaki et al., 2007; Leal, 2017), as well as PMN degranulation response (Blannin et al., 
1997; Robson, 1999a; Robson-Ansley et al., 2007) and ROS production (Yaegaki et al., 2008). 
It has been proposed that these functional changes may increase the incidence of URTS in 
athletes by inhibiting the efficiency of antigen clearance by PMN (Smith and Pyne, 1997). Very 
few theories have been proposed as to why PMN function is reduced following a period of 
intensified training, however Robson-Ansley et al. (2007) proposed that it may be due to an 
influx of immature PMN with less efficient functions compared to mature PMN. In addition, 
they proposed that the stimulation of PMN throughout an ITP by antigen challenge could 
dampen PMN ability to function in response to a secondary stimulation.  
The completion of high-intensity exercise has been reported to elevate cortisol concentration 
(Verde et al., 1992; Gray et al., 1993; VanBruggen et al., 2011; Hough et al., 2011; Hough et 
al., 2013) which will effectively regulate the release of immature PMN from the bone marrow 
into circulation (Cavalcanti et al., 2006). Following successive exercise sessions, the pool of 
mature PMN may deplete due to apoptosis or necrosis, thus leaving immature PMN as the 
predominant subtype in circulation. It has been reported that immature PMN have a lower 
phagocytic activity and less granular enzymes compared to mature PMN (McCarthy and Dale, 
1988; Yang and Hill, 1991), therefore this may be responsible for the lower PMN function 
reported after periods of intensified training. Furthermore, following stimulation by antigen 
challenge, it appears PMN respond less effectively to a secondary stimulation with recovery 
of its functionality occurring over time (Prasad et al., 1991). During the repeated exercise 
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performed over an ITP, circulating PMN would be particularly exposed to an increased number 
of DAMP derived  from skeletal tissue microtrauma. The continual exposure of DAMP to the 
circulating PMN may therefore weaken a response to  future antigen challenge.  
Resting and exercise-induced neutropenia has been reported in athletes who completed an 
8-day period of intensified training (Svendsen et al., 2016) and in swimmers over a 6-month 
competitive season (Hooper et al., 1995). In contrast, Robson-Ansley et al. (2007) reported 
an acute rise in resting PMN concentration following a 12-day period of intensified training 
which corresponded with an acute elevation to plasma cortisol levels which may have 
restricted the PMN from migrating into inflamed tissue, thus elevating the number of PMN in 
circulation.  
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2.4 Cytokines and the Susceptibility to Upper-Respiratory Tract Symptoms  
Intensified periods of training which may lead to a state of NFOR or the OTS have previously 
been associated with the depression of several immune functions (Gleeson and Williams, 
2013). This impaired immune function following an ITP has also been associated with an  
increased susceptibility to URTS (Peters and Bateman, 1983; Neiman et al., 1990; Verde et 
al., 1992; Gomez-Merino et al. 2005; Morgado et al., 2012). There is little clarity however on 
which particular immune impairment is causing the increased susceptibility to URTS.  
The development of URTS appears to be the most common reason for athletes to visit sport 
medicine clinics (Neiman, 1994) and is the primary medical condition reported by elite athletes 
at both the winter and summer Olympic games (Robinson and Milne, 2000; Reeser et al., 
2002; Nabhan et al., 2016; Yoon et al., 2018). The development of URTS in athletes during 
such a critical period of training is likely to have repercussions on an athlete’s physical 
performance capacity and even participation of events. Therefore, it is of importance to 
determine the aetiology of URTS present in athletes following a period of intensified training.  
The aetiology of URTS is often thought to derive from the infiltration of infectious antigens, 
such as the Epstein-Barr virus (Gleeson et al., 2002; Cox et al., 2004). Research completed 
by Spence et al. (2007) however reported that out of 37 URTS episodes reported by elite 
athletes during a 5-month training and competition period, infectious antigens were only 
clinically present in 11 episodes. It is therefore encouraged that physicians should consider 
both infectious and non-infectious mechanisms, such as allergens and pollutants, when 
athletes report of URTS (Cox et al., 2007; Spence et al., 2007). Consequently, this present 
study will refer to episodes of upper-respiratory discomfort as URTS rather than upper-
respiratory tract infection, otherwise referred to as URTI in the literature, as this investigation 
could not objectively define the aetiology of upper-respiratory discomfort without a clinical 
diagnosis.  
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Numerous studies have reported an inverse relationship between a decreased slgA 
concentration and an increased susceptibility to URTS in overtrained athletes (Neiman et al., 
1990; Heath et al., 1992; Mackinnon and Hooper, 1996; Gleeson et al., 1999; Neiman, 2002; 
Fahlman et al., 2005; Neville et al., 2008; Gleeson and Bishop, 2013). Very few studies 
however have examined whether an association exists between blood immune parameters 
and the susceptibility to URTS in overtrained athletes. It has been reported that following a 6-
week elevation of training load in elite swimmers, a reduced production of pro-inflammatory 
cytokines (IL-1, IL-6, IL-12, TNF-α, MIP-1) by antigen-stimulated monocytes and dendritic cells 
was associated with an increased number of URTS episodes (Morgado et al., 2012). In 
contrast, Gleeson and Bishop (2013) reported no changes in pro-inflammatory cytokine 
production by antigen-stimulated whole blood culture in athletes who were reportedly more 
susceptible to illness compared to healthy controls. The difference in findings may be due to 
the fact that Gleeson and Bishop (2013) used whole blood culture which would include total 
pro-inflammatory cytokine production from a milieu of nucleated cells present rather than a 
particular, purified cell type such as monocytes or dendritic cells.  
Nonetheless, pro-inflammatory cytokine production from leukocytes such as PMN may reflect 
an individual’s capacity to mediate an inflammatory response against antigen challenge 
(Gleeson and Bishop, 2013). PMN is the primary leukocyte mobilized during the acute 
inflammatory response to antigen challenge (Freire and Van Dyke, 2013), therefore their ability 
to produce pro-inflammatory cytokines may significantly contribute to the inflammatory 
response against antigen challenge. Decreased pro-inflammatory cytokine production by 
antigen-stimulated PMN may therefore reduce antigen clearance which could leave the body 
susceptible to foreign antigens. Reduced antigen clearance may ultimately lead to the 
increase in reported URTS in overtrained athletes. This thesis will therefore examine whether 
a 12-day period of intensified training alters the production of TNF-α and IL-8 by antigen-
stimulated PMN. It will also examine whether participants have a greater incidence of self-
reported episodes of URTS during the ITP.  
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2.5 Cytokines and Symptoms of Overtraining  
Many hypotheses have been proposed to explain the signs and symptoms associated with 
overtraining such as the ‘glycogen depletion’ theory (Costill et al., 1988), the ‘glutamine theory’ 
(Newaholme et al., 1991) and the ‘monotony theory of overtraining’ (Foster and Lehmann, 
1997). None of these hypotheses however account for all of the observed symptoms 
associated with overtraining. The ‘cytokine hypothesis of overtraining’ by Smith (2000) implies 
that many reported symptoms associated with overtraining could derive from a prolonged state 
of systemic (blood-bound) inflammation induced by an elevation in pro-inflammatory 
cytokines. Exercise which requires the eccentric contraction of skeletal tissue is associated 
with the development of muscle and connective tissue microtrauma (Peake et al., 2005). The 
onset of microtrauma leads to the release of DAMP that initiates an inflammatory response 
through the release of pro-inflammatory cytokines from circulating leukocytes (Perry, 1992). 
Often with sufficient recovery, this inflammatory response would be alleviated by therapeutic 
mechanisms such as anti-inflammatory cytokine release (Opal and DePalo, 2000). When 
excessive exercise is performed with limited recovery however, it is theorised that the 
mechanisms to mediate the inflammatory response are insufficient. A dysregulated 
inflammatory response will thus evoke a chronic inflammatory response which results in 
systemic inflammation (Smith, 2000). Smith (2000) postulates that the development of 
systemic inflammation can result in the development of the signs and symptoms associated 
with overtraining.  
Many of the symptoms associated with overtraining may occur from central nervous system 
dysfunction, such as loss of appetite, increased fatigue, increased sensitivity to pain, and a 
loss of motivation (Fry et al., 1991). Evidence suggests that the development of systemic 
inflammation can mediate an immune system-to-brain communication by activating the vagus 
nerve and acting upon TLR found upon macrophage-like cells in circumventricular organs and 
choroid plexus (Dantzer et al., 2008). Engagement of immune system-to-brain communication 
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leads to the activation of microglia and astrocytes cells (Chesnokova et al., 2016). Microglia 
and astrocytes are glial cells that support and protect neurons (Hartenstein and Giangrane, 
2018). When activated, microglia and astrocytes can release pro-inflammatory molecules 
such as cytokines, chemokines, ROS, and nitric oxide, thus developing a state of 
neuroinflammation (Chesnokova et al., 2016). Neuroinflammation is implicated in the 
development of non-specific psychological and behavioural changes that are collectively 
known as sickness behaviours (Kent et al., 1992). These sickness behaviours include 
anorexigenic behaviour (Romanatto et al., 2007), chronic fatigue (Morris et al. 2015), mood 
decline (Miller and Raison, 2016) and an increased sensitivity to pain (Zhang and An, 2007). 
Sickness behaviours are often reported by athletes who have developed NFOR or the OTS 
(Fry et al., 1991; Meeusen et al., 2013). It is possible that the persistent production of pro-
inflammatory cytokines from excessive exercise may lead to a state of acute systemic 
inflammation that is responsible for the development of sickness behaviours that are reported 
by NFOR/OTS athletes.  
In her description of the ‘cytokine hypothesis for overtraining’, Smith (2000) failed to identify 
which particular cell-type may be leading to the over-production of pro-inflammatory cytokines 
within the blood. As PMN are the primary leukocyte mobilized during a state of acute 
inflammation (Freire and Van Dyke, 2013), their ability to produce pro-inflammatory cytokines 
may significantly contribute to initiating the inflammatory response against antigen challenge. 
Persistent exercise-induced increases in pro-inflammatory cytokines by antigen-stimulated 
PMN may therefore significantly contribute to a state of acute systemic inflammation that 
evokes the development of sickness behaviours reported by NFOR/OTS athletes. 
A level of acute systemic inflammation will be countered by a delayed release of anti-
inflammatory cytokines in an attempt to mitigate the inflammatory response and prevent it from 
becoming chronic (Opal and DePalo, 2000). Exposure to anti-inflammatory cytokines, such as 
IL-10, may lead to the downregulation of pro-inflammatory cytokine receptors (Zhang and An, 
2007). IL-10 has been reported to downregulate the expression of pro-inflammatory cytokines 
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from macrophages and PMN (Fiorentino et al., 1991; Wang et al., 1994) which may explain 
the reduction of pro-inflammatory cytokine production by antigen-stimulated dendritic cells and 
monocytes (Morgado et al., 2012) as detailed in Chapter 2.4, and could imply that pro-
inflammatory cytokine production by PMN may also be affected after an ITP. A reduced pro-
inflammatory cytokine activity by PMN may ultimately mediate a less effective inflammatory 
response that impairs the body’s ability to successfully clear antigen challenge. Consequently, 
this could be one of several immune impairments responsible for the pathogenesis of reported 
URTS in athletes who have NFOR or the OTS, as highlighted in Chapter 2.4. 
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2.6 Thesis Rationale, Aim and Hypothesis 
Rationale 
PMN are the primary leukocyte mobilized during the earliest phases of acute inflammation 
(Freire and Van Dyke, 2013), therefore their ability to produce pro-inflammatory cytokines will 
contribute to the initiation and propagation of the inflammatory response against antigen 
challenge.  
PMN microbicidal function decreases following an ITP (Robson et al., 1999a; Robson-Ansley 
et al., 2007; Yaegaki et al., 2007; Yaegaki et al., 2008; Leal., 2017). It is however not known 
whether the ability of PMN to mediate an inflammatory response via the production of pro-
inflammatory cytokines is affected by an ITP. An altered pro-inflammatory cytokine response 
by antigen-stimulated PMN may lead to a less effective inflammatory response which impairs 
antigen clearance from the body. Ultimately, this could be one of several immune impairments 
responsible for the pathogenesis of reported URTS in athletes who have developed NFOR or 
the OTS.  
The reported decrease in PMN microbicidal function following a period of intensified training 
has been suggested as a potential biological marker in highlighting stress states such as 
NFOR and the OTS (Gleeson, 2002; Yaegaki et al., 2008). If a reduced pro-inflammatory 
cytokine response by antigen-stimulated PMN is evident following a period of intensified 
training then this would further suggest that a comprehensive overview of PMN function could 
be used as a sensitive biological marker to highlight the onset of overtraining in athletes.  
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Aim 
The aim of this study therefore was to investigate whether a 12-day ITP would alter resting 
and/or exercise-induced IL-8 and TNF-α production by antigen-stimulated PMN.  
Hypothesis 
Resting and exercise-induced IL-8 and TNF-α production by antigen-stimulated PMN will 
decrease following the ITP. 
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Chapter 3. Methods 
3.1 Ethical Approval 
This study was granted ethical approval by the University of Bedfordshire Research Ethics 
Committee. Ethical approval (Appendix 8.1) was completed in agreement with the principles 
of medical research involving human subjects established by the World Medical Association 
Declaration of Helsinki (64th WMA General Assembly, Fortaleza, Brazil, October 2013). All 
potential participants were thoroughly briefed with the study structure, aims and potential risks, 
as highlighted in the participant information sheet (Appendix 8.2). Prior to participation, 
participants provided informed consent (Appendix 8.3) and completed a health screen and 
physiological testing questionnaire (Appendix 8.4).  
3.2 Statement of Collaborative Work 
This Masters by Research thesis document forms part of a wider group project including work 
completed by Dr. Diogo Luìs Campos Vas Leal during his PhD at the University of 
Bedfordshire, titled ‘The Use of Endocrine and Immune Biomarkers to Highlight Overreaching’ 
(Leal, 2017). This current MSc thesis presents data for ten participants, two of which were 
recruited during the 12 month MSc project. The other eight participants were recruited as part 
of Dr. Leal’s work. However, the author of this present thesis played an integral role in the 
recruitment process and data collection for the eight participants presented in Dr. Leal’s PhD 
thesis. Thus, Mr. Thorley was involved in conducting the trials and exercise protocols for all 
participants presented here, two of which he completed independently to Dr. Leal. These 
participants both completed the protocol over the timeframe necessary for the completion of 
the Masters by Research project. Other participants were recruited during the MSc project but 
they did not complete the entire protocol and thus are not included. Data collected and 
analysed by Mr. Thorley included anthropometric measures, physiological responses to acute 
exercise and to the ITP, TRIMP scores, and blood PMN concentration. The hypothesis tested 
within this MSc thesis is novel and is independent of Dr. Leal’s work. IL-8 and TNF-α 
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concentrations by antigen-stimulated PMN reported in this present thesis were not 
investigated by Dr. Leal. Thus, all cytokine assays, data analysis and interpretation presented 
here is novel and is solely Mr. Thorley’s work.   
3.3 Participants 
Ten male participants were recruited who were aged between 18-40 years (Table 3.1). 
Participants were required to live a healthy lifestyle in order to participate in this study. In 
accordance to the Physical Activity and Public Health joint stance by the American College of 
Sport Medicine and the American Heart Foundation (2007) (Haskell et al., 2007), participants 
verbally confirmed with the researcher that they had been involved in either five days of 
moderate-aerobic exercise per week for a minimum of thirty minutes or alternatively three days 
of vigorous-intensity aerobic exercise per week for a minimum of twenty minutes. Confirmation 
of each participants weekly exercise regime would be determined when initially quantifying 
participants’ normal training load prior to the study, as seen in Chapter 3.7.  
Participants were recruited on the basis that they did not possess any traits highlighted in the 
exclusion criteria which was detailed within the participant information sheet. Participants 
verbally confirmed that they did not meet any of the exclusion criteria. The exclusion criteria 
for this study was the following: 
• Night shift workers: Night shift workers were unable to participate in this study due 
to potentially irregular hormonal and immune secretory patterns influenced by a 
distorted circadian rhythm (Arendt, 2010). Irregular hormonal patterns can distort 
immune function (Taneja, 2018). A lack of sleep often highlighted by night shift workers 
could also impact psychological, performance and general health parameters during 
the study (Watson, 2017). 
• Smokers: Smokers were prevented from participating as this habit can negatively 
influence pulmonary variables such as V̇O2max, forced expiratory function, respiratory 
muscle strength and forced vital capacity (Tantisuwat and Thaveeratitham, 2014). 
34 
 
Pulmonary dysfunction would impair physical performance levels during the V̇O2max 
test, the main trials and the ITP. 
• Females: The menstrual cycle has been reported to impact leukocyte numbers and 
modulate their activity (Oertelt-Prigione, 2012), therefore to prevent this influence on 
the present study, females were excluded.  
• History of URTS: Previous experience with URTS prior to the completion of the study 
may influence the interpretation of URTS results. Therefore, participants verbally 
confirmed with the researcher that they had not experiences any URTS within the last 
2 weeks prior to the study and that they were in a  healthy state when beginning the 
study. 
The participants anthropometric and physiological measurements can be found in Table 3.1. 
Table 3.1: Anthropometric and physiological measurements of participants. Values 
expressed as mean ± SD.  
 Mean + SD 
Age (years) 21.1 ± 4.4 
Height (cm) 177.4 ± 6.9 
Body mass (kg) 73.0 ± 5.9 
V̇O2max  (mL.kg-1.min-1) 58.1 ± 5.2 
HRmax (beats.min-1) 194 ± 9 
N =10  
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Participants were expected to attend seventeen trials over the course of the study (Figure 
3.1). These trials included:  
• 1 Familiarisation trial 
• 2 Experimental main trials, completed before (MTPRE) and after (MTPOST) the ITP.  
• 2 V̇O2max tests, completed before (VO2PRE) and after (VO2POST)  the ITP. 
• 12 Intensified exercise sessions  
All trials took place at the University of Bedfordshire Sport Science laboratories with the 
exception of one participant who completed their weekend training at a local leisure facility as 
they were unable to visit the laboratory at weekends. To ensure this participant completed 
their training over the weekend when unsupervised, participants were requested to provide 
photographic evidence of HR data (from the allocated HR monitor) and treadmill velocity data 
(from the treadmill interface) so that it could be reported back to the researcher immediately 
following the completion of exercise. Likewise, the participant was also required to video 
himself completing the training sessions to ensure the accuracy of the HR and treadmill 
interface data. An in-depth review of each trial completed during the study can be found in 
Chapter 3.6.  
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Figure 3.1: Study design schematic. 
37 
 
3.4 Questionnaires  
3.4.1 Jackson Score Upper-respiratory Tract Symptom Questionnaire 
All participants were required to complete a Jackson score URTS questionnaire during MTPRE 
and MTPOST (Appendix 8.5). This questionnaire recorded the severity of the following URTS: 
• Sneezing 
• Headache 
• Malaise 
• Nasal Discharge 
• Sore Throat 
• Cough 
• Ear Ache 
• Hoarseness 
• Joint Aches and Pains 
• Fever 
• Chilliness 
Each symptom was marked upon its degree of discomfort using the Jackson score (Jackson 
et al., 1958). Discomfort was measured using a Likert scale which ranged from 0 (none at all), 
1 (mild), 3 (moderate), and 4 (severe). The total sum of all URTS scores was calculated so 
that MTPRE and MTPOST scores could be compared to see whether URTS had worsened.  
3.4.2 Recovery-Stress Questionnaire for Athletes 
The RESTQ-76 Sport questionnaire assesses the recovery – stress state in athletes which 
indicates the degree of physical/mental fatigue accumulated from both sport-specific and 
external stressors over the past three days and nights (Kellmann and Kallus, 2001) (Appendix 
8.6). This questionnaire was completed by participants during MTPRE and MTPOST.  
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Participants answered seventy-seven questions relating to their perception of stress and 
recovery. These questions were divided into four main scales named general stress, general 
recovery, sport stress and sport recovery. Within the ‘general’ scales of stress and recovery, 
there were forty-eight non-specific questions and within the ‘sport’ scales are twenty-eight 
sport-specific questions. Within each main scale, a number of different subscales are 
represented that reflect specific changes to general and sport-related stress and recovery. 
Table 3.2 depicts each main scale and its given subscale.  
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Table 3.2: Main scales and subscales used within the RESTQ-76 Sport Questionnaire.  
Scale Subscale 
 
 
 
General Stress 
General Stress 
Emotional Stress 
Social Stress 
Conflicts 
Fatigue 
Lack of Energy 
Somatic Complaints 
 
 
General Recovery 
Success 
Social Relaxation 
Somatic Relaxation 
General Wellbeing 
Sleep Quality 
 
Sport Stress 
Disturbed Breaks 
Burnout 
Fitness/Injury 
 
 
Sport Recovery 
Being in Shape 
Personal Accomplishments 
Self-Efficiency 
Self-Regulation 
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Each question depicts a Likert scale that ranged from 0 (being never) to 6 (always), 
participants were required to mark their proposed answer. High scores received from the 
stress-related questions reflected a high level of subjective stress whilst high scores from the 
recovery-related questions indicated a good recovery from exercise and an increased sense 
of well-being.  
3.5 Diaries  
3.5.1 Training Diary  
If participants were performing exercise that was not associated with the set study design, 
they were required to complete a training diary so that these sessions could be incorporated 
into the calculation to determine individual training load. (Appendix 8.7). The training diary 
required participants to detail the following information:  
• The date of the session 
• Sport completed  
• Exercise completed  
• Resting HR (HRrest) 
• Average HR (HRaverage) 
• Maximal HR (HRmax) 
• RPE of session 
Participants were given a HR monitor (Polar FS1, Polar, Kempele, Finland) and instructed to 
record their HR variables for each external training session.  This data would be used to 
quantify training load, as presented in Chapter 3.7.  
3.5.2 Food Diary 
Participants were required to complete a food diary 24 hours prior to MTPRE (Appendix 8.8). 
The completion of the food diary allowed for the standardization and replication of caloric and 
macronutrient intake prior to MTPOST. Standardization of caloric intake prevented dietary habits 
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from influencing energy expenditure which have altered the participants work capacity and 
RPE between MTPRE and MTPOST. A digital weighing scale (Salter 1036BKSSDR, HoMedics 
Group Ltd, Kent, UK) was given to participants so that consumed food could be weighed and 
thus replicated to prevent miscalculation of caloric intake. Participants were encouraged to 
standardize their weighing habits when completing the food diary, for example weighing food 
prior to being cooked. Participants were reminded the day before MTPOST to replicate the exact 
food diary that they had reported on the MTPRE food diary. 
3.6 Trials 
Below is a list of all trials [in chronological order] that were completed by participants during 
the study. 
3.6.1 Visit 1: Familiarisation trial 
A familiarisation trial was performed at least ~1 week before the commencement of the study 
to familiarize each participant with the logistics and equipment used throughout each main 
trial. Participants were requested to arrive at the University of Bedfordshire Sport Science 
laboratories at 11:40 am to begin the familiarisation process. Familiarisation and main trials 
were completed at the same time of day to ensure immune function was not influenced by 
circadian alterations to endocrine or immune function which may alter cytokine production by 
PMN. No blood samples were collected during the familiarisation. The exercise completed 
during this trial was an exact replica of what participants would be completing during the main 
trials. No blood samples were taken however participants did complete all the required 
questionnaires and forms (consent form, health screening questionnaire, URTS questionnaire, 
and RESTQ-76 Sport questionnaire) that would be expected to be completed during each 
main trial. 
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3.6.2 Visit 2: Main trial (MTPRE) 
The first main experimental trial (MTPRE) was completed within a week of the familiarisation 
session so information regarding the proposed logistics of MTPRE would not be forgotten. 
Participants were requested to attend the University of Bedfordshire Sport Science Laboratory 
in a fasted state (> 4 hours fasted) and sufficiently hydrated to prevent hypohydration and 
changes to electrolyte balance which could compromise performance (Sawka et al., 2007). In 
accordance with the ACSM Position Stand on Exercise and Fluid Replacement (2007), 
participants were required to consume ~500 mL of fluid at least 2 hours before exercise to 
promote adequate hydration (Sawka et al., 2007). Upon arrival (~11:40 am), participants were 
immediately escorted to the bathroom where they provided a urine sample for analysis. Urine 
osmolality was determined using a urine refractometer (Pocket PAL-OSMO, Atago Vitech 
Scientific, Horsham, UK). A value of < 700 mOsmol.kg-1 indicated that the participant was in 
a euhydrated state (Sawka et al., 2007) and therefore was eligible to complete the main trial. 
If participants exceeded 700 mOsmol.kg-1 then the trial was rearranged for a different day as 
it was essential that participants began the main trial at 12:00.  
On return to the laboratories, participants read and completed the following documents; Health 
Screen and Physiological Testing Questionnaire, REST-Q 76 Sport Questionnaire and the 
Jackson URTS questionnaire. Participants were fitted with a HR monitor and HRrest was 
measured using a HR monitor (Polar FS1, Polar, Kempele, Finland) whilst participants 
completed the documents. Body mass and height were measured using a weighing scale 
(Tanita, BWB0800, Tanita, Amsterdam, Netherlands) and stadiometer (HAR-92.602, Holtain, 
Crymych, Wales), respectively. At ~11:55 am, blood was collected from participants’ 
antecubital fossa via venepuncture.  
Participants initially completed a warm-up which consisted of a 3 minute jog at 6 km.h-1  prior 
to the completion of exercise. At 12:00 pm, participants began the experimental exercise 
protocol (abbreviated as RPETR) which was completed on a motorised treadmill (D-79576, 
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Weil am Rhein, Germany). The RPETR was a 30 minute, self-paced treadmill run which 
alternated between 1 and 4 minute stages. During each stage, participants were required to 
alter the treadmill velocity to correspond to a rating of perceived exertion (RPE) score which 
was determined using a Borg scale (Borg, 1970). For all 1 minute stages, participants were 
required to run at an RPE of 11, which equated to light exertion. For all 4 minute stages, 
participants ran at a speed corresponding to an RPE of 15, or a hard exertion. Participants 
were not allowed to see their respective treadmill velocity as this may have influenced their 
relative RPE to each stage. A 1% incline gradient was set to mimic the environmental cost of 
outdoor running (Jones and Doust, 1996) and HR, RPE and treadmill velocity were collected 
in the final 15 seconds of each stage (Appendix 8.9 for data sheet).  
Immediately following the completion of RPETR, a second blood sample was collected. A 1 
hour rest period commenced where participants were instructed to remain seated. Following 
the 1 hour rest period, a 10 km time trial (TT) performance test was completed on a motorised 
treadmill at a 1% incline. Verbal support was given to encourage participants to finish the time 
trial as fast as possible. Participants were blinded to the time or distance completed during the 
10 km TT as this may have influenced their time to completion. As a result, the treadmill display 
interface was covered. An overview of the main trial can be found in Figure 3.2. 
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Figure 3.2:  Visual timescale of MTPRE and MTPOST
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3.6.3 Visit 3:  V̇O2max Test (VO2PRE) 
Participants were required to complete a V̇O2max test before the completion of the ITP, this 
baseline test has been abbreviated as ‘VO2PRE’ throughout the thesis.  
A V̇O2max test is a gold-standard method of measuring the maximum amount of O2 a person 
can utilize during intense aerobic exercise (Tipton, 2006) and can therefore reflect an 
individual’s health status and relative work capacity (Tipton, 2006). VO2PRE was performed 24 
hours following MTPRE and 24 hours prior to the 1st session of the ITP to determine the 
participants’ baseline aerobic capacity. The ACSM defined that the average aerobic capacities 
of normally active 20-29 year old males is 45-51 mL.kg.min-1 (Bushman, 2017). Participants 
were therefore required to exceed a V̇O2max score of 45 mL.kg.min-1 to ensure that they were 
aerobically fit enough to complete the entire ITP. VO2PRE was completed 24 hours after MTPRE 
so that the high-intensity nature of the V̇O2max test would not influence resting immune function 
on the morning of MTPRE.  
Upon arrival to the laboratories, the participants were re-familiarised with the equipment and 
completed a warm-up prior to the test, this was completed for 3 minutes at 6 km.h-1, with an 
incline gradient set at 1%. A submaximal treadmill running test at a 1% incline gradient was 
then performed for 16 minutes, which was divided into 4 x 4 minute stages. Participants were 
encouraged to choose a speed between 7 km.h-1 to 12 km.h-1 to begin the test. Prior to the 
test, participants were given the opportunity to test each speed intensity to see which speed 
best suited their relative aerobic fitness capacity. After the completion of each 4 minute stage, 
the treadmill speed was increased by 1 km.h-1. This test was used to measure participants’ 
oxygen uptake (V̇O2) at submaximal velocities.  
Participants were given a 20 minute rest period where they remained seated for the entirety. 
To determine V̇O2max, an incremental treadmill running test was run to volitional exhaustion. 
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The test was completed in 1 minute stages, with the first stage beginning at a 1% increment 
gradient and increasing by 1% after each stage until V̇O2max criteria was achieved.  
V̇O2max was established in accordance with The British Association of Sport and Exercise 
Science Position Statement on the Physiological Assessment of the Elite Competitor (1992) 
(Bird and Davison, 1997) which states that 3 of the following 5 criteria must be achieved by 
the participant: 
• An observed plateau in V̇O2 in correspondence with increased exercise intensity. This 
plateau can be defined as less than a 3% increase (< 2 mL.kg-1.min-1) in V̇O2 after an 
increase in exercise intensity.  
• An achieved HR which is 10 beats.min-1 away from the participants’ age-predicted 
HRmax. This can be calculated by 220 – participants age (years).  
• An achieved respiratory exchange ratio of > 1.15. 
• An RPE of > 18.  
• Volitional exhaustion achieved. 
The treadmill speed was consistent throughout the entirety of the test and was set at the speed 
that was achieved during the submaximal test when participants’ HR reached 150 beats.min1. 
HR and RPE were collected in the last 15 seconds of each stage. An overview of VO2PRE can 
be seen in Figure 3.3.
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Figure 3.3: Visual timescale of VO2PRE and VO2POST
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3.6.4 Calculation of Velocity at V̇O2max 
During the 12 day ITP, each participant was given individualised exercise intensities based off 
their given velocity at V̇O2max (vV̇O2max). Specifically, participants were asked to run for 70 
minutes at 55% of vV̇O2max and 20 minutes at 75% vV̇O2max during a 90-minute continuous 
treadmill run which was employed throughout the 12 day ITP. To calculate the individualised 
percentages of vV̇O2max, V̇O2 was regressed upon the increases of speed from the 
submaximal test completed during VO2PRE and a linear equation was obtained. The speed-
V̇O2 relationship from the submaximal test was then extrapolated to obtain 55% and 75% of 
vV̇O2max. 
3.6.5 Visit 4 – 15: Intensified Training Period (ITP) 
24 hours following VO2PRE, participants began the first exercise protocol of the 12 day ITP. 
Participants completed 3 different exercise protocols which repeated 4 times over the 12 days. 
The variety of such protocols was aimed to reduce the monotony of the training protocols 
which could have led to participants losing interest. The protocols used within the study design 
were as follows: 
1. A 90-min continuous treadmill run, divided into one stage of 70 minutes at 55% of the 
individuals’ vV̇O2max and one 20 minutes stage at 75% vV̇O2max. 
2. 5 km time trial 
3. A 70 minute, self-paced treadmill run at a speed corresponding to an RPE of 12 (light) 
on the Borg scale for the first 30 minutes, at 13 (somewhat hard) for the following 30 
minutes, and at 15 (hard) for the final 10 minutes 
Treadmill incline remained at 1% throughout the entirety of each exercise protocol. 
Participants were allowed to drink water ad libitum during each protocol. Treadmill velocities, 
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distances, HRrest and HRaverage were collected over each exercise protocol to quantify the total 
training load of the ITP, as highlighted in Chapter 3.7. 
3.6.6 Visit 16 – 17: Main trial and V̇O2max Test (MTPOST and VO2POST) 
A second experimental main trial (abbreviated as MTPOST) was completed 24 hours following 
the completion of the ITP. MTPOST would measure whether the ITP had altered participants’ 
physiological, immune, psychological, and performance variables..   
Likewise, a second V̇O2max test (abbreviated as VO2POST) was completed 24 hours following 
the completion of the MTPOST main trial. VO2POST was performed 24 hours after the ITP to 
determine whether changes to physiological stress or fitness level influenced changes to 
immune function. MTPOST and VO2POST were performed by replicating the same protocol that 
was used during MTPRE and VO2PRE, respectively.  
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3.7 Training Load  
The premise of the ITP was designed to increase (or ‘intensify’)  participants’ training load 
compared to their normal training load. A training impulse (TRIMP) equation was used to 
quantify whether participants’ training load had increased during the ITP compared to their 
baseline training load. Twelve days prior to the beginning of the study protocol, participants 
were asked to complete a training diary of their daily physical exercise activities. During each 
exercise session, participants were required to measure their HRrest, HRaverage and HRmax, plus 
the duration of each session. Measurement of these HR variables was completed using a HR 
monitor (Polar FS1, Polar, Kempele, Finland) that was provided to the participant. This 12 day 
period was known as the ‘baseline’ period and was used to determine participant’s normal 
training load prior to participation. The TRIMP for each session was calculated using the 
following formula developed by Banister (1991):  
𝑡𝑖𝑚𝑒 𝑜𝑓 𝑠𝑒𝑠𝑠𝑖𝑜𝑛 (𝑚𝑖𝑛𝑠) ×  ∆𝐻𝑅 × 𝑦 
∆𝐻𝑅 =
(𝐻𝑅𝑎𝑣𝑒𝑟𝑎𝑔𝑒 − 𝐻𝑅𝑟𝑒𝑠𝑡)
(𝐻𝑅𝑚𝑎𝑥 − 𝐻𝑅𝑟𝑒𝑠𝑡)
 
𝑦 = 𝑤𝑒𝑖𝑔ℎ𝑡𝑖𝑛𝑔 𝑓𝑎𝑐𝑡𝑜𝑟 (0.64𝑒1.92𝑥) 
𝑒 = 𝑏𝑎𝑠𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑁𝑎𝑝𝑖𝑒𝑟𝑖𝑎𝑛 𝑙𝑜𝑔𝑎𝑟𝑖𝑡ℎ𝑚 
𝑥 =  ∆𝐻𝑅 
Banister (1991) 
 
The sum of TRIMP scores measured after each exercise session during the baseline period 
were compared to the sum of TRIMP scores of each exercise session measured during the 
ITP (from the set exercise sessions and from external training sessions). This would determine 
whether participants were truly training with an elevated training load during the ITP. 
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3.8 Whole Blood Collection and Isolation Techniques 
3.8.1 Venepuncture 
Whole blood was collected from an antecubital vein via venepuncture using a 21G needle with 
quickshield (Vacuette, Greiner Bio-One, Stonehouse, UK) immediately pre RPETR and 
immediately post RPETR. Blood was collected by a trained phlebotomist with an up-to-date 
hepatitis B vaccination. Three 5 mL Vacuette containers, treated with K3 
Ethylenediaminetetraacetic acid (K3EDTA) (Vacuette, Greiner Bio-One, Stonehouse, UK) 
were collected and immediately used for analysis.  
3.8.2 Neutrophil Isolation 
To isolate PMN from whole blood, 5 mL of Lympholyte-polyTM  (Cederlane Laboratories, 
Burlington, Canada) was gently dispensed into a 15 mL falcon tube (BD Biosciences, Oxford, 
UK). An equal amount of heparinised whole blood was carefully layered on top of the 
Lympholyte-polyTM medium. Lympholyte-polyTM is a density gradient medium (density of 1.133 
g/mL-1) that provokes a separation of granulocytes from other blood cells based on their 
particular buoyant density. The falcon tube was placed into a temperature-controlled 
centrifuge (Heraeus, Heraeus Multifuge X3R, Thermo Fisher Scientific, Waltham, 
Massachusetts, USA) and spun for 35 minutes at 500 x g, with the temperature set at 20 °C. 
Centrifugal acceleration and deceleration levels were set to 2 and 1 respectively. 
Following the centrifugal process, a density gradient between blood cells had formed (Figure 
3.5). Peripheral blood mononuclear cells (PBMC) have a lower buoyant density (< 1.133 g.mL-
1) than PMN and red blood cells (RBC) (> 1.133 g.mL-1). Granulocytes and RBC can thus 
sediment through the Lympholyte-polyTM medium whilst PBMC maintain at the medium 
interface. Granulocytes segregate within a separate band located below the PBMC whilst the 
RBC further sediment through the medium due to their significantly higher buoyant density. 
The RBC will subsequently aggregate at the bottom of the tube. The PMN are located in the 
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granulocyte band which also included basophils and eosinophils, therefore the PMN harvested 
are not 100% PMN and may contain a very small fraction of contamination.   
 
Figure 3.4: Example result of 5 mL heparinised whole blood / 5 mL Lympholyte-polyTM post-
centrifuge. Cell types of banded based on their buoyant density.  
If the granulocyte band was clearly observable, a Pasteur pipette was used to discard the 
plasma and PBMC layer so that PMN could be reached and harvested.  A previously made 
solution consisting of 25 mL sterile-filtered water (BioReagent, Sigma-Aldrich, Gillingham, 
Dorset, UK) and 25 mL Dulbecco’s Modified Eagles Cell Medium (Sigma-Aldrich, Gillingham, 
Dorset, UK) supplemented with glucose (4500 mg.L-1), sodium pyruvate (110 mg.L-1) and L-
glutamine was added to the harvested PMN and centrifuged for 10 minutes at 400 x g to 
suspend, wash and culture the PMN. After 10 minutes, the supernatant was discarded and 1 
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mL of AIM-V Serum Free Cell Medium (AlbuMAXTM, Gibco,  Waltham, Massachusetts, USA) 
supplemented with L-glutamine, gentamicin sulfate (10 µg.mL-1) and streptomycin sulphate 
(50 µg.mL-1) was suspended upon the PMN pellet. The PMN pellet was unsuspended into the 
cell medium and the supernatant was used for the following cell counts and cytokine assay.  
3.9 Determination of Blood Neutrophil Concentration 
The PMN supernatant, as described in Chapter 3.8, was used to determine participants’ blood 
PMN concentration. PMN supernatant (20 μL) was suspended in 100 μL of 10X, pH 7.4 
phosphate buffer saline (PBS). Cells were counted using 2 different methods. Determination 
of blood PMN concentration was completed using a handheld cell counter (Scepter, Merck 
Millipore, Germany). One participant’s blood PMN concentration were counted using 
hemocytometry due to a fault with the handheld cell counter.  
Cell counting via the handheld cell counter was completed by attaching a 60 μm disposable 
tip (PHCC60050, Scepter, Merck Millipore, Billerica, Massachusetts, USA) onto the device 
and then following the instructions onscreen. PMN were detected using Ohm’s Law: 
𝑉 = 𝐼𝑅 
𝑉 = 𝑉𝑜𝑙𝑡𝑎𝑔𝑒;  𝐼 = 𝐶𝑢𝑟𝑟𝑒𝑛𝑡;  𝑅 = 𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 
As cells pass through the counters aperture, resistance increases causing a subsequent 
increase in voltage. Voltage changes are recorded as spikes and spikes of the same 
magnitude are allocated into a histogram and interpreted as a cell concentration.  
Hemocytometry is the cell counting technique using a hemocytometer grid and a microscope. 
A cover slip was first fixed upon the hemocytometer by moistening the surface using an 
exhaled breath. The observation of ‘Newton’s rings’ would determine whether the cover slip 
was appropriately affixed upon the hemocytometer. 20 μL of 0.2% trypan blue dye was mixed 
with 20 μL of PMN suspended in AIM-V. 10 μL of the trypan blue stain/PMN mix was then 
pipetted at the edge of the cover slip which would travel onto the hemocytometer grid. The 
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hemocytometer grid was placed under the microscope to be counted. Live cells were counted 
from 5 squares of the grid (4 corners squares, 1 centre square). Live PMN would appear 
colourless and bright whereas dead cells would stain blue and become non-refractile. This 
reaction is based on the principle that live cells possess intact cell membranes which do not 
allow the dye to enter whereas necrotic or PMN which underwent apoptosis allow the dye to 
accumulate within the cell (Strober, 2001). To calculate the particular cell concentration per 
mL, the following equation was used: 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑃𝑀𝑁 𝑖𝑛 5 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 × 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑢𝑛𝑡𝑒𝑑 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 (5)  × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 × 104 
3.10 Neutrophil Stimulation Assay 
This assay was performed to elicit IL-8 and TNF-α production by the harvested PMN. PMN 
were stimulated with a commercially-available LPS extracted from Escherichia-coli (Sigma 
Aldrich, Gillingham, Dorset, UK). Commercially-available LPS was prepared by reconstituting 
1 mg LPS in 1 mL cell medium (1 mg.mL-1).  
A 24-well plate was acquired and wells were divided into ‘stimulated’ and ‘unstimulated’ for 
each time point (pre and post RPETR). For all wells, 250 μL of PMN cultured with AIM-V was 
added, followed by a further 750 μL of AIM-V Serum Free Cell Medium to prevent any serum 
component contamination. For all ‘stimulated’ wells, 10 µL of reconstituted LPS was added. 
Samples were placed into an incubator (HERA CELL 240i, Thermo Scientific, Loughborough, 
UK) for 18 hours at 37 °C, 5% CO2. It was expected that the incubatory period would allow the 
PMN to release an optimal concentration of both IL-8 and TNF-α in response to LPS 
stimulation into the culture (Bazzoni et al., 1991; Djeu et al., 1990).  
The following day, each well was transferred into individual Eppendorf’s. All samples were 
placed into a microcentrifuge (Pico 17, Heraeus, Thermo Scientific, Loughborough, UK) and 
spun for 400 x g for 5 minutes to suspend the PMN. The PMN culture were then transferred 
into new Eppendorf’s and frozen at -80 °C until cytokine analysis was performed. The non-
stimulated cytokine concentrations reflect the basal level of cytokine production by PMN to 
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any stimulation which may have occurred pre-harvest and therefore act as control 
measurements. The cytokine concentration by antigen-stimulated PMN reflects the level of IL-
8 and TNF-α produced in response to an in vitro sterile infection.  
3.11 Cytokine Analysis  
In this present study, TNF-a and IL-8 concentrations by antigen-stimulated and non-stimulated 
control PMN were determined using direct sandwich Enzyme-Linked Immunosorbent Assay 
(ELISA) tests (Bender MedSystems GmbH, Vienna, Austria). All ELISA tests were performed 
by the same researcher to avoid inter-experimenter variability. Each assay was completed by 
following the manufacturers guidelines. All completed ELISA tests for the present study can 
be found in Table 3.3.  
Table 3.3: Information of ELISA tests used within the present study.  
ELISA Range (pg.mL-1) Sensitivity  
(pg.mL-1) 
 
Uncoated Human TNF-α  
 
4 – 500 
 
4 
 
Uncoated Human IL-8  
 
2 – 250 
 
2 
 
Uncoated 96-well microplates (Costar 9018, CorningTM, New York, USA)  were used to plate 
all samples collected throughout the study. Prior to its use, each microplate underwent a 
coating process which involved adding pre-titrated, purified anti-human IL-8 and TNF-α 
capture antibodies to each well followed by a 24 hour incubation which provoked the 
hydrophobic binding of the capture antibody to the plastic well. All samples used on the IL-8 
ELISA were diluted 1:25 with 1X PBS (pH 7.4) to fit onto the ELISA standard curve as previous 
attempts of the IL-8 ELISA with undiluted samples significantly exceeded the maximal range. 
Samples were aliquoted into duplicates to identify any pipetting error or well contamination 
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that could cause skewed concentrations. The intra-assay coefficient of variance for each 
assay are displayed in Table 3.4. To reduce interassay variation, samples from each individual 
participant were run on the same ELISA.  
Table 3.4: Intra-assay coefficient of variance (%) of all completed ELISA tests.  
ELISA Number of Samples Intra-assay Coefficient of 
Variance (%) 
Uncoated Human TNF-α  
 
32 10.3 
Uncoated Human TNF-α 
 
40 14.5 
Uncoated Human TNF- α 
 
8 6.6 
Uncoated Human IL-8 
 
40 4.5 
Uncoated Human IL-8 40 10 
 
A plate washer (Asys Atlantis, Biochrom Ltd, Cambridge, UK) was used to rinse and aspirate 
wash buffer (1X PBS, 0.05% Tween -20) when required. A 450 nm plate reader (Tecan, Infinite 
F200 Pro, Männedorf, Switzerland) was used to calculate the optical densities of the ELISA 
plate. The software Magellan™ version 7.1 (Tecan GmbH, Männedorf, Switzerland) was used 
to automatically determine the standard curve from the optical densities which provided the 
raw concentrations of each sample. 25 samples violated the standard curve, these were the 
following samples: 
• Participant 1: (1) MTPRE, post RPETR, unstimulated (IL-8) (2) MTPRE, post RPETR, 
stimulated (IL-8). 
• Participant 2: (1) MTPRE, pre RPETR, unstimulated (2) MTPOST, post RPETR, 
unstimulated (IL-8). 
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• Participant 3: (1) MTPRE, pre RPETR, stimulated (IL-8) (2) MTPRE, post RPETR, 
unstimulated (IL-8) (3) MTPRE, post RPETR, stimulated (IL-8) (4) MTPRE, pre RPETR, 
unstimulated (IL-8); (5) MTPRE, pre RPETR, stimulated (IL-8) (6) MTPRE, post RPETR, 
stimulated (IL-8).  
• Participant 5: (1) MTPRE, pre RPETR, unstimulated (IL-8) (2) MTPRE, pre RPETR, 
stimulated (IL-8) (3) MTPRE, post RPETR, stimulated (IL-8) (4) MTPRE, pre RPETR, 
unstimulated (IL-8) (5) MTPOST, pre RPETR, stimulated (IL-8) (6) MTPOST, post RPETR, 
unstimulated (IL-8) (7) MTPOST, post RPETR,  stimulated (IL-8).  
• Participant 6: (1) MTPRE, post RPETR, unstimulated (IL-8) (2) MTPRE, post RPETR, 
stimulated (IL-8) (3) MTPOST, post RPETR, unstimulated (IL-8) (4) MTPOST, post- RPETR, 
stimulated (IL-8).  
• Participant 7: (1) MTPRE, post RPETR, stimulated (IL-8) (2) MTPOST, pre RPETR, 
unstimulated (IL-8) (3) MTPOST, post RPETR, unstimulated (IL-8).  
• Participant 8: (1) MTPRE, post RPETR, stimulated (IL-8).  
 
A linear equation was produced to extrapolate the standard curve to calculate the raw 
concentration of these violated samples from their mean optical density. An example of this 
process is demonstrated in Figure 3.6.   
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Figure 3.6: Linear equation (𝑦 = 𝑚𝑥 + 𝑐) produced from the standard curve of a completed 
IL-8 ELISA. The linear equation was rearranged to: 
𝑥 = (𝑦 − 𝑐) 𝑚⁄  
y = mean optical density of sample (in duplicates) 
x = IL-8 concentration (pg.mL-1) 
 
23 samples were undetectable (< 2 pg.mL-1  for IL-8 ELISA; < 4 pg.mL-1  for TNF-α ELISA) 
during analysis, these were the following:  
Participant 1: (1) MTPRE, pre RPETR, unstimulated (IL-8 + TNF-α) (2) MTPRE, post RPETR, 
stimulated (TNF-α) (3) MTPRE, pre RPETR, unstimulated (TNF-α) (4) MTPOST, post RPETR, 
unstimulated (TNF-α).  
Participant 2: (1) MTPRE, pre RPETR, unstimulated (TNF-α) (2) MTPRE, post RPETR, 
unstimulated (TNF-α) (3) MTPOST, pre RPETR, unstimulated (TNF-α); MTPOST, post RPETR, 
unstimulated (TNF-α). 
Participant 3: (1) MTPRE, pre RPETR, unstimulated (IL-8) 
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Participant 4: (1) MTPOST, pre RPETR, unstimulated (TNF-α). 
Participant 7: (1) MTPOST, pre RPETR, unstimulated (TNF-α); (2) MTPOST, post RPETR, 
unstimulated (TNF-α).  
Participant 8: (1) MTPOST, pre RPETR, unstimulated (TNF-α); (2) MTPOST, pre RPETR, 
unstimulated; (3) MTPOST, post RPETR, unstimulated (TNF-α).  
Participant 9: (1) MTPRE, pre RPETR, stimulated (IL-8) 
Participant 10: (1) MTPRE, pre RPETR, unstimulated (TNF-α) (2) MTPRE, pre RPETR, 
stimulated (TNF-α) (3) MTPRE, post RPETR, unstimulated (TNF-α) (4) MTPRE, post RPETR, 
stimulated (TNF-α) (5) MTPOST, pre RPETR, unstimulated (IL-8 + TNF-α) (6) MTPOST, post 
RPETR, stimulated (IL-8 + TNF-α). 
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3.12 Statistical Analysis 
SPSS version 22 (SPSS inc., Chicago, IL.) was used to complete all statistical analyses. Prior 
to analysis, data was checked for normality using Q-Q plots and the Shapiro-Wilk Test. A 
paired samples t-test was used to compare training load variables, hydration status, V̇O2max 
scores, 10 km time to completion, URTS scores and the RESTQ-76 Sport Questionnaire 
before and after the ITP. A two-way repeated measured analysis of variance (ANOVA) (trial 
(MTPRE x MTPOST) x time (pre RPETR x post RPETR)) was completed on HR, treadmill velocity, 
RPE, blood PMN concentration and IL-8 and TNF-α production by antigen-stimulated PMN. 
Where significant main effects were found, Bonferroni post-hoc corrections were used to 
examine the difference between individual trial and time conditions.  
A calculation of Cohen’s d effect size (ES) was used when statistical significance was not 
accepted. This was completed on 10 km time to completion results, URTS scores and the 
absolute exercise-induced change of TNF-α and IL-8 concentrations by antigen-stimulated 
PMN to measure the size of difference between the means (Cohen, 1988). Effect sizes of 0.2, 
0.5 and 0.8 were considered small, medium and large, respectively (Durlack, 2009). The 
following equation was used to calculate ES: 
𝑑 =
𝑀𝑒𝑎𝑛1 − 𝑀𝑒𝑎𝑛2
𝑆𝐷𝑝𝑜𝑜𝑙𝑒𝑑 
 
𝑆𝐷𝑝𝑜𝑜𝑙𝑒𝑑 =  √(𝑆𝐷𝑔𝑟𝑜𝑢𝑝12 + 𝑆𝐷𝑔𝑟𝑜𝑢𝑝22)/2 
Cohen (1988) 
All data was presented as mean ± standard deviation (SD). Statistical significance was 
accepted at P < 0.05. To clarify which work was completed during the duration of the Masters 
by Research, the results section is presented in two section.  
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3.13 Data Presentation 
The data presented within Results will be divided into two sections. Chapter 4 will present data 
that was collected from the two participants (participant 9 and 10) who were recruited and 
analysed by Mr. Thorley during this Masters by Research project (~12 months). Chapter 5 will 
present a retrospective analysis of all 10 participants who completed the entire protocol 
(Figure 3.1), that is: eight participants recruited by Dr. Leal and Mr. Thorley plus two 
participants recruited solely by Mr. Thorley. This clarifies exactly which aspects of recruitment 
and data collection was completed by Mr. Thorley during the period required for the award of 
Masters by Research.   
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Chapter 4. Results (Two Participants) 
4.1 Changes to Training Load 
4.1.1 Total Exercise Duration  
Total exercise duration was longer (885 ± 187 min, P = 0.171) during the ITP in both 
participants compared to the total exercise duration measured during the baseline period 
(350 ± 21 min) (Figure 4.1). 
 
Figure 4.1: Total exercise duration (min) measured during the ITP compared to the total 
exercise duration measured during the baseline period. 
 
4.1.2 Total Sum of TRIMP Scores  
The total sum of TRIMP scores measured during the ITP was higher (1509 ± 426, P = 0.234)  
during the ITP in both participants compared to the sum of TRIMP scores measured during 
the baseline period (568 ± 88) (Figure 4.2) 
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Figure 4.2: Sum of TRIMP scores measured during the ITP compared to the sum of TRIMP 
scores measured during the baseline period. 
4.2 Hydration Status 
Urine osmolality was 105 ± 37 mOsmol.kg-1 higher at MTPOST (350 ± 198 mOsmol.kg-1) when 
compared to the urine osmolality measured at MTPRE (245 ± 162 mOsmol.kg-1) (P = 0.751).  
 
4.3 Physiological Responses to RPETR 
4.3.1 Heart Rate Responses to RPETR 
No trial effect (MTPRE x MTPOST) was present in HR responses across the RPETR (F1, 1 = 4.298, 
P = 0.286) (Figure 4.3). HRaverage of the RPETR was 152 ± 18 beats.min-1 during MTPRE and 153 
± 24 beats.min-1 during MTPOST.  
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Figure 4.3: HR responses (beats.min-1) across the RPETR  measured at MTPRE and MTPOST . 
Values expressed as mean ± SD of 2 participants.  
4.3.2 Treadmill Velocity Responses to RPETR 
No trial effect (MTPRE x MTPOST) was present in treadmill velocity responses across the RPETR 
(F1, 1 = 1.993, P = 0.392) (Figure 4.4) Average treadmill velocity of the RPETR was 9.8 ± 2.2 
km.h-1  at MTPRE and 10.8 ± 2.8 km.h-1 at MTPOST 
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Figure 4.4: Treadmill velocity (km.h-1) measured across the RPETR at MTPRE and MTPOST. 
Values expressed as mean ± SD of 2 participants. 
4.4 Maximal Volume of Oxygen Uptake (V̇O2max) 
Mean V̇O2max values decreased by 1.5 ± 2.1 mL.kg-1.min-1 at VO2POST (54.5 ± 3.5 mL.kg-1.min-
1) compared to VO2PRE values (56 ± 1.4 mL.kg-1.min-1) (P = 0.5) (Figure 4.5).  
  
 
Figure 4.5: Comparison of Participant 9 and 10’s individual V̇O2max values at VO2PRE and 
VO2POST  
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4.5 Markers of Overtraining 
4.5.1 Changes to 10 km Time Trial Time to Completion 
The time to completion scores of the 10 km TT completed by participant 2 was 01:20 
(mm:ss) longer at MTPOST (54:16) compared to MTPRE (52:56) (Figure 4.6). Participant 9 did 
not complete this test. 
 
Figure 4.6: Time to completion (min) scores at MTPRE and MTPOST.  
 
4.5.2 Changes in the Severity of Upper-respiratory Tract Symptoms  
Statistical analysis could not be performed on this variable as participant 1 and 2 did not 
report any URTS at MTPRE or MTPOST. 
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4.5.3 Changes to Perceived Stress and Recovery 
The ‘general stress’ scores increased by 0.1 ± 0.9 from MTPRE (3.9 ± 0.9) to MTPOST (4 ± 0) 
(P = 0.951) (Figure 4.7). The ‘sport stress’ scores increased by 3.7 ± 0.5 from MTPRE (3.2 ± 
0.7) to MTPOST (6.9 ± 1.2) (P = 0.061). The ‘general recovery’ scores increased by 0.1 ± 0.4 
from MTPRE (13.8 ± 3.1) to MTPOST (13.9 ± 3.5) (P = 0.795). The ‘sport recovery’ scores 
decreased by 2.4 ± 1.5 from MTPRE (15 ± 0.4) to MTPOST (11.7 ± 1.6) (P = 0.260).  
 
Figure 4.7: Comparison of RESTQ 76 Sport scores measured at MTPRE and MTPOST.  
Values expressed as mean ± SD of 2 participants.  
4.6 Changes to Blood Neutrophil Concentration  
No main effect for trial (MTPRE x MTPOST) was present in the concentration of blood PMN  (F1,1 
= 1.059, P = 0.491). Mean blood PMN concentration was 0.3 ± 0.4 cells x106.mL-1 higher at 
MTPOST (2.0 ± 0.7 cells x106.mL-1) than at MTPRE (1.7 ± 0.3 cells x106.mL-1). There was also no 
main effect for time (Pre RPETR x Post RPETR) (F1, 1 = 6.547, p = 0.237). Mean blood PMN 
concentration was 0.3 ± 0.1 cells x106.mL-1 higher at post RPETR (2 ± 0.6 MTPRE cells x106.mL-
1) than at pre RPETR (resting) (1.7 ± 0.5 cells x106.mL-1). No interaction effect of time over trial 
was present (F1,1 = 0.648, P = 0.722) (Figure 4.8). 
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Figure 4.8: Comparison of blood PMN concentration (cells x106.mL-1) in response to the 
RPETR at MTPRE and MTPOST. 
Values expressed as mean ± SD of 2 participants. 
 
4.7 Tumor Necrosis Factor-α Production by Antigen-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of TNF-α concentration 
produced by antigen stimulated PMN (F1, 1 = 3.974, P = 0.295). Mean TNF-α concentration 
was markedly lower at MTPOST (24 ± 5 pg.mL-1)  compared to MTPRE (99 ± 43 pg.mL-1). No 
significant main effect for time (Pre RPETR x Post RPETR) was reported (F1, 1 = 30.822, P = 
0.113). Mean TNF-α concentration was higher post RPETR (82 ± 21 pg.mL-1) compared to pre 
RPETR (resting) (42 ± 28 pg.mL-1). No significant interaction effect of time over trial was present 
(F1, 1 = 4.921, P = 0.196) (Figure 4.9).  
The absolute change of TNF-α concentration in response to the RPETR decreased from 39 ± 
33 pg.mL-1 at MTPRE (36% increase) to -12 ± 6 pg.mL-1 at MTPOST (40% decrease). (Figure 
4.10). 
 
0
0.5
1
1.5
2
2.5
3
3.5
MTPRE MTPOST
P
M
N
 (
x
1
0
6
·m
L
-1
 )
Pre RPETR (resting)
Post RPETR
69 
 
 
Figure 4.9: TNF-α concentration (pg.mL-1) produced by antigen-stimulated PMN in response 
to the RPETR at MTPRE and MTPOST. 
Values expressed as mean ± SD of 2 participants. 
 
Figure 4.10: Comparison of the absolute exercise (RPETR)-induced change in TNF-α 
concentration (pg.mL-1) at MTPRE and MTPOST. 
All values were expressed as mean ± SD of 2 participants. 
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4.8 Tumor Necrosis Factor-α Production by Non-stimulated Neutrophils 
Statistical analysis could not be performed on this variable due to participant 2 having 
undetected levels (< 4 pg.mL-1) of TNF-α concentration at all time points. At MTPRE, participant 
1’s TNF-α production by non-stimulated PMN decreased from 19 pg.mL-1  pre RPETR to 11 
pg.mL-1 post RPETR. A similar decrease was observed at MTPOST, with participant 1’s TNF-α 
production by non-stimulated PMN decreasing from 7 pg.mL-1  pre RPETR to 5 pg.mL-1
  post 
RPETR.  
 
4.9 Interleukin-8 Production by Antigen-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of IL-8 concentration 
produced by antigen-stimulated PMN (F1, 1 = 0.529, P = 0.6). Mean IL-8 concentration was 
lower at MTPOST (831 ± 340 pg.mL-1)  compared to MTPRE (3835 ± 3788 pg.mL-1). No significant 
main effect for time (Pre RPETR x Post RPETR) was reported (F1, 1 = 1.167, P = 0.475). Mean 
IL-8 concentration was higher post RPETR (3417 ± 2727 pg.mL-1) compared to pre RPETR 
(resting) (1249 ± 720 pg.mL-1). No significant interaction effect of time over trial was present 
(F1, 1 = 0.950, P = 0.508) (Figure 4.11).  
The absolute change of IL-8 concentration in response to the RPETR decreased from 3235 ± 
6097 pg.mL-1 at MTPRE (109% increase) to 265 ± 38 pg.mL-1 at MTPOST (26% increase) (Figure 
4.12). 
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Figure 4.11: IL-8 concentration (pg.mL-1) produced by antigen-stimulated PMN in response 
to the RPETR at MTPRE and MTPOST. 
Values expressed as mean ± SD of 2 participants. 
 
Figure 4.12: Comparison of the absolute exercise (RPETR)-induced change in IL-8 
concentration (pg.mL-1) at MTPRE and MTPOST. 
All values were expressed as mean ± SD of 2 participants. 
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4.10 Interleukin-8 Production by Non-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of IL-8 concentration 
produced by non-stimulated PMN (F1, 1 = 1.479, P = 0.438). Mean IL-8 concentration was lower 
at MTPOST (153 ± 20 pg.mL-1) compared to MTPRE (679 ± 412 pg.mL-1). No significant main 
effect for time (Pre RPETR x Post RPETR) was found (F1, 1 = 22.281, P = 0.133). Mean IL-8 
concentration was higher post RPETR (501 ± 178 pg.mL-1) compared to pre RPETR (resting) 
(332 ± 213 pg.mL-1). No significant interaction effect of time over trial was present (F1, 1 = 0.149, 
P = 0.765) (Figure 4.13).  
 
Figure 4.13: IL-8 concentration (pg.mL-1) produced by non-stimulated PMN in response to 
the RPETR at MTPRE and MTPOST. 
Values expressed as mean ± SD of 2 participants. 
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Chapter 5. Results (Retrospective Analysis of Ten Participants) 
5.1 Changes to Training Load 
5.1.1 Total Exercise Duration  
Participant 2 and 6 did not record their exercise duration during the baseline period. Total 
exercise duration was significantly longer during the ITP (984 ± 356 min, P < 0.001) in all 10 
participants compared to the total exercise duration measured during the baseline period (415 
± 418 min) (Figure 5.1) thus all recorded participants increased their training load. 
 
 
Figure 5.1: Total exercise duration (min) measured during the ITP compared to the total 
exercise duration measured during the baseline period.  
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5.1.2 Total Sum of TRIMP Scores  
Participant 2 and 6 did not record their HR and exercise duration during the baseline period, 
therefore their TRIMP scores for this period could not be established. The total sum of 
TRIMP scores measured during the ITP was higher (1535  ± 580, P < 0.001) in all 10 
participants compared to the sum of TRIMP scores measured during the baseline period 
(597 ± 580) (Figure 5.2).  
 
Figure 5.2: Sum of TRIMP scores measured during the ITP compared to the sum of TRIMP 
scores measured during the baseline period.  
 
 
5.2 Hydration Status 
There was no difference in the mean urine osmolality measured pre RPETR at MTPRE (285 ± 
235 mOsmol.kg-1)  compared to the urine osmolality measured pre RPETR at MTPOST (404 ± 
271 mOsmol.kg-1) (P = 0.34).  
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5.3 Physiological Responses to RPETR 
5.3.1 Heart Rate Responses to RPETR 
No trial effect (MTPRE x MTPOST) was present in HR responses across the RPETR (F1, 9 = 1.204, 
P = 0.29) (Figure 5.3). HRaverage of the RPETR was 150 ± 4 beats.min-1 during MTPRE and 146 ± 
5 beats.min-1 during MTPOST.  
 
Figure 5.3: HR responses (beats.min-1) across the RPETR  measured at MTPRE and MTPOST. 
Values expressed as mean ± SD of 10 participants.  
 
5.3.2 Treadmill Velocity Responses to RPETR 
No trial effect (MTPRE x MTPOST) was present in treadmill velocity responses across the RPETR 
(F1, 9 = 0.659, P = 0.773) (Figure 5.4). Average treadmill velocity of the RPETR was 10.6 ± 0.7 
km.h-1  at MTPRE and 11 ± 0.7 km.h-1 at MTPOST.  
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Figure 5.4: Treadmill velocity (km.h-1) measured across the RPETR at MTPRE and MTPOST. 
Values expressed as mean ± SD of 10 participants. 
 
5.4 Maximal Volume of Oxygen Uptake (V̇O2max) 
There was no difference between V̇O2max values (58.1 ± 5.2 mL.kg-1.min-1) at VO2PRE  and 
VO2POST (57.7 ± 6.1 mL.kg-1.min-1) (P = 0.696) (Figure 5.5). All 10 participants V̇O2max varied 
in response following the ITP (Figure 5.6).  
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Figure 5.5: Comparison of V̇O2max values at VO2PRE and VO2POST  
Values expressed as mean ± SD of 10 participants. 
 
Figure 5.6: Comparison of individual V̇O2max values at VO2PRE and VO2POST.  
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5.5 Markers of Overtraining 
5.5.1 Changes to 10 km Time Trial Time to Completion 
Participant 1, 4, and 9 did not complete the 10 km TT. The time to completion scores of the 
10 km TT measured at MTPRE (46:20 ± 05:39 (mm:ss)) and MTPOST (47:31 ± 05:12) were not 
significantly different (P = 0.497). A small ES (d = 0.32) increase in completion time was 
evident at MTPOST. Absolute change between MTPRE and MTPOST was 01:11 ± 00:27 (Figure 
5.7). Five out of the seven measured participants had slower time to completion scores at 
MTPOST (Figure 5.8).  
 
Figure 5.7: Comparison of the 10 km TT time to completion (min) scores at MTPRE and 
MTPOST.  
Values expressed as mean ± SD of 7 participants. 
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Figure 5.8: Comparison of individual time to completion (min) scores at MTPRE and MTPOST.  
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5.5.2 Changes in the Severity of Upper-respiratory Tract Symptoms  
The sum of URTS scores reported by participants increased in six of the ten participants at 
MTPOST compared to MTPRE (Figure 5.9). No significant differences were observed between 
the URTS subscales ‘sneezing’, ‘malaise’, ‘nasal discharge and obstruction’, ‘sore throat’, 
‘cough’, ‘ear ache’, ‘hoarseness’, ‘fever’, ‘chilliness’ and ‘joint aches and pains’ measured at 
MTPRE and MTPOST (P > 0.05). The ‘headache’ subscale significantly increased at MTPOST (P < 
0.05) (Figure 5.10). Large ES were found between mean malaise (d = 0.90), nasal obstruction 
(d = 1.12), joint aches and pain (d = 1.10) and nasal discharge (d = 0.89) scores measured at 
MTPRE and MTPOST. 
 
Figure 5.9: Comparison of the total sum of URTS scores reported by participants at MTPRE 
and MTPOST. Participant 2, 9, and 10 did not report any URTS at either MTPRE and MTPOST. 
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Figure 5.10: URTS scores reported by participants for each subscale at MTPRE and MTPOST . 
Participants did not report any incidences of ear ache or fever at MTPRE or MTPOST. * = 
significantly different to MTPRE (p < 0.05).  
Values expressed as mean ± SD of 10 participants. 
5.5.3 Changes to Perceived Stress and Recovery 
The mean ‘general stress’ (P = 0.04) and ‘sport stress’ (P = 0.01) scores were significantly 
elevated at MTPOST compared to MTPRE (Figure 5.11). At MTPOST, seven participants had an 
increased ‘general stress’ score (Figure 5.12) and nine participants had an increased ‘sport 
stress’ score (Figure 5.13). The ‘fitness injury’ subscale within the ‘sport stress’ scale was 
significantly higher at MTPOST (P = 0.005) (Figure 5.14). No significant differences were 
observed when comparing the ‘general recovery’ and ‘sport recovery’ scales between MTPRE 
and MTPOST (P = > 0.05). 
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Figure 5.11: Comparison of RESTQ-76 Sport scores measured at MTPRE and MTPOST. * = 
significantly different to MTPRE (p < 0.05).  
All values expressed as mean ± SD of 10 participants. 
 
Figure 5.12: Comparison of individual RESTQ-76 Sport ‘General Stress’ scores at MTPRE and 
MTPOST.  
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Figure 5.13: Comparison of individual RESTQ-76 Sport ‘Sport Stress’ scores at MTPRE and 
MTPOST. 
 
Figure 5.14: Comparison of each subscale within the RESTQ 76 Sport ‘General Stress’ and 
‘Sport Stress’ scales at MTPRE and MTPOST. * = significantly different from MTPRE (P < 0.05).  
All values expressed as mean ± SD of 10 participants.  
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5.6 Changes to Blood Neutrophil Concentration  
No main effect for trial (MTPRE x MTPOST) was present in the concentration of blood PMN  (F1,9 
= 0.461, P = 0.51) between MTPRE (2.0 ± 0.1 cells x106.mL-1) and MTPOST (2.1 ± 0.2 cells 
x106.mL-1). There was however a significant main effect for time (Pre RPETR x Post RPETR) 
(F1, 9 = 15.656, p = < 0.01)  
During MTPRE, blood PMN concentration significantly rose from 1.8 ± 0.5 cells x106.mL-1  pre 
RPETR to 2.1 ± 0.5 cells x106.mL-1 post RPETR (P = 0.02). During MTPOST, blood PMN 
concentration significantly rose from 1.9 ± 0.6 cells x106.mL-1 pre RPETR to 2.3 ± 0.6 cells 
x106.mL-1 post RPETR (P = 0.016) (Figure 5.15). No significant interaction effect of trial over 
time was present (F1,9 = 0.447, P = 0.521). 
 
Figure 5.15: Comparison of blood PMN concentration (cells x106.mL-1) in response to the 
RPETR at MTPRE and MTPOST. * = Significantly different to pre RPETR at MTPRE ; ** = 
Significantly different to pre RPETR at MTPOST  (P < 0.05).  
Values expressed as mean ± SD of 10 participants.  
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5.7 Tumor Necrosis Factor-α Production by Antigen-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of TNF-α concentration 
produced by antigen-stimulated PMN (F1, 6 = 4.727, P = 0.073). Mean TNF-α concentrations 
were lower at MTPOST (107 ± 35 pg.mL-1)  compared to MTPRE (183 ± 40 pg.mL-1). There was 
however a significant main effect for time (Pre RPETR x Post RPETR) (F1, 6 = 10.999, P = 0.016).  
In response to the RPETR completed at MTPRE, TNF-α concentration increased from 22 ± 35 
pg.mL-1 pre RPETR (resting) to 356 ± 206 pg.mL-1 post RPETR (P = 0.004). In response to the 
RPETR completed at MTPOST, TNF-α concentration similarly increased from 28 ± 25 pg.mL-1 
pre RPETR (resting) to 162 ± 173 pg.mL-1 post RPETR (P = 0.047) (Figure 5.16). No significant 
interaction effect of trial over time was present (F1, 6 = 5.433, P = 0.058). 
The absolute increase in TNF-α  concentration in response to the RPETR decreased from 317 
± 232 pg.mL-1 at MTPRE (789% increase) to 170 ± 191 pg.mL-1 (639% increase) at MTPOST  (P 
= 0.056; d = 1.20) (Figure 5.17). Individual TNF-α concentrations varied per individual, with 
concentrations ranging from 1 – 541 pg.mL-1. 
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Figure 5.16:  TNF-α concentration (pg.mL-1) produced by antigen-stimulated PMN in response 
to the RPETR at MTPRE and MTPOST. * = significantly different to pre RPETR at MTPRE; ** = 
significantly different to pre RPETR at MTPOST (P < 0.05).  
 All values were expressed as mean ± SD of 10 participants. 
 
Figure 5.17:  Comparison of the absolute exercise (RPETR)-induced increase in TNF-α 
concentration (pg.mL-1)  at MTPRE and MTPOST.  
All values were expressed as mean ± SD of 10 participants.. 
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5.8 Tumor Necrosis Factor-α Production by Non-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of TNF-α concentration 
produced by non-stimulated PMN (F1, 3 = 1.634, P = 0.291). Mean TNF-α concentration was 
lower at MTPRE (67 ± 58 pg.mL-1) compared to MTPOST (88 ± 60 pg.mL-1). Additionally, no main 
effect for time (Pre RPETR x Post RPETR) was observed (F1, 3 = 1.223, p = 0.349). Mean TNF-
α concentration was greater post RPETR (138 ± 113 pg.mL-1) compared to pre RPETR (17 ± 5 
pg.mL-1). No significant interaction effect of trial over time was present (F1, 3 = 4.480, P = 0.125) 
(Figure 5.18).  
 
Figure 5.18: TNF-α concentration (pg.mL-1) produced by non-stimulated PMN in response to 
the RPETR at MTPRE and MTPOST. 
All values were expressed as mean ± SD of 6 participants. 
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5.9 Interleukin-8 Production by Antigen-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of IL-8 concentration 
produced by non-stimulated PMN (F1, 7 = 1.555, P = 0.252). Mean IL-8 concentration was lower 
at MTPOST (6100 ± 1756 pg.mL-1) compared to MTPRE (7761 ± 1735 pg.mL-1). There was 
however a significant main effect for time (Pre RPETR x Post RPETR) (F1, 7 = 6.548, P = 0.038).  
In response to the RPETR completed at MTPRE, IL-8 concentration significantly increased from 
4884 ± 5290 pg.mL-1 pre RPETR (resting) to 10607 ± 5025 pg.mL-1 post RPETR (P = 0.033). In 
response to the RPETR completed at MTPOST, IL-8 concentration did not significantly increase 
from pre RPETR (4650 ± 4539 pg.mL-1) to post RPETR (6455 ± 5956 pg.mL-1) (P = 0.199) 
(Figure 5.19). No significant interaction effect of trial over time was present (F1, 7 = 1.301, P = 
0.292). 
The absolute increase of IL-8 concentration in response to the RPETR decreased from 5753 ± 
7419 pg.mL-1 at MTPRE (117% increase) to 2003 ± 4083 pg.mL-1 at MTPOST (51% increase) (P 
= 0.261; d = 2.25) (Figure 5.20). Individual IL-8 concentrations by antigen-stimulated PMN 
significantly varied per individual, with concentrations ranging from 95 – 18908 pg.mL-1. 
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Figure 5.19: IL-8 concentration (pg.mL-1) produced by antigen-stimulated PMN in response to 
the RPETR at MTPRE and MTPOST.* = Significantly different to pre RPETR at MTPRE (P < 0.01).  
All values were expressed as mean ± SD of 10 participants. 
 
Figure 5.20: Comparison of the absolute exercise (RPETR)-induced increase in IL-8 
concentration (pg.mL-1) at MTPRE and MTPOST. 
All values were expressed as mean ± SD of 10 participants. 
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5.10 Interleukin-8 Production by Non-stimulated Neutrophils 
No main effect for trial (MTPRE x MTPOST) was present in measures of IL-8 concentration 
produced by non-stimulated PMN (F1, 6 = 2.465, P = 0.167). Mean IL-8 concentration was lower 
at MTPRE (3736 ± 1367 pg.mL-1) compared to MTPOST (6945 ± 2488 pg.mL-1). Additionally, there 
was no main effect for time (Pre RPETR x Post RPETR) (F1, 6 = 0.500, p = 0.506). Mean IL-8 
concentration was greater post RPETR (5819 ± 1899 pg.mL-1) compared to pre RPETR (resting) 
(4862 ± 1812 pg.mL-1). No significant interaction effect of trial over time was present (F1, 6 = 
0.236, P = 0.645) (Figure 5.21).  
 
Figure 5.21: IL-8 concentration (pg.mL-1) produced by non-stimulated PMN in response to the 
RPETR at MTPRE and MTPOST. 
All values were expressed as mean ± SD of 10 participants. 
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Chapter 6. Discussion 
The purpose of this present study was to investigate whether a 12-day ITP would alter resting 
or exercise-induced TNF-α and IL-8 production by antigen-stimulated PMN. The main finding 
from this study is that in response to the RPETR at MTPOST, the absolute increase in exercise-
induced TNF-α and IL-8 concentration produced by antigen-stimulated PMN was lower 
compared to the absolute exercise-induced rise in response to the RPETR at MTPRE. As a 
result, the experimental hypothesis of this present study was accepted – pro-inflammatory 
cytokine production by antigen-stimulated PMN decreased following the ITP.  
6.1 Markers of Overtraining 
Many symptoms associated with states of FOR, NFOR, and the OTS have been reported in 
previous literature (Fry et al., 1991; Robson-Ansley and Costa, 2014). One of the challenges 
in completing good quality research in the area of overtraining is that it requires the 
confirmation that markers of overtraining are present. In this study, various physiological and 
psychological markers were implemented to identify apparent markers of overtraining in 
participants. The use of the 10 km TT performance test would confirm whether a decline In 
physical performance capacity was present at MTPOST. The RESTQ-76 Sport questionnaire 
would identify whether participants had become more fatigued and developed more 
physiological and psychological stress at MTPOST. The Jackson URTS questionnaire would 
identify whether participants had developed new  URTS or had increased the severity of 
existing URTS at MTPOST.  
General and Sport-related Stress 
Following the 12-day ITP, general and sport-related stress scores had significantly increased 
in all ten participants, including the two participants who were specifically recruited for this 
thesis. In particular, the subscale ‘fitness/injury’ was significantly higher at MTPOST. For this 
subscale to have increased, participants had experienced the following scenarios more 
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frequently; ‘parts of my body were aching’; ‘my muscles felt stiff or tense during performance’; 
‘I had muscle pain after performance’; and ‘I felt vulnerable to injuries’. An increased 
perception of stress following an ITP was similarly reported by Hough et al. (2013) who used 
a shorter version of the RESTQ-76 Sport questionnaire (RESTQ-52) and found that ‘fatigue’ 
and ‘burnout’ scores were significantly higher after an 11-day ITP. 
The muscle discomfort and pain reported by the end of the ITP may have resulted from skeletal 
tissue microtrauma. Skeletal tissue microtrauma is a common biological adaptation in 
response to exercise that incorporates eccentric activity such as the treadmill running 
incorporated throughout this study (MacIntyre et al., 1995). In addition, the lack of recovery 
time between exercise sessions (24 hours) would have developed an imbalance between 
training stress and recovery. In line with Selye’s (1936) GAS theory, a lack of recovery 
following exposure to novel stressors with insufficient recovery will result in the acquirement 
of biological maladaptation such as muscle fatigue and injury.  
The incidence of injury and increased muscular discomfort are commonly reported symptoms 
by athletes who have developed NFOR or the OTS (Fry et al., 1991; Birrer et al., 2013). Birrer 
et al. (2013) measured the prevalence of key clinical symptoms in 127 Swedish athletes who 
had been diagnosed with either NFOR or the OTS. It was reported that 30% of NFOR/OTS 
athletes experienced more than 5 injuries per year and 73% had experienced feelings of 
exacerbated muscular fatigue. The findings in this present study that highlights an increased 
perceived injury risk and greater muscular fatigue in participants could therefore support the 
notion that these participants may had become overreached by the end of the ITP.  
Physical Performance Capacity 
One of the primary outcomes following the development of NFOR or the OTS is a decrease 
to physical performance capacity (Jeukendrup et al., 1992; Urhausen et al., 1998; Halson et 
al., 2002; Meeusen et al., 2006; Dupuy et al., 2010; La Meur et al., 2014; Aubrey et al., 2015). 
In this present study, a 10 km TT performance test was completed at MTPRE and MTPOST to 
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identify whether the ITP had impacted participants’ physical performance capacity. No 
significant differences between time to completion scores measured at MTPRE and MTPOST 
were observed, however further investigation highlighted that a small ES in completion time 
was evident at MTPOST. The completion time measured at MTPOST was 2.5% slower, or 01:11 
± 0:27 (mm:ss) longer in duration than the time measured at MTPRE. This decrease in 
completion time was evident in five out of the seven recorded participants. In addition, one out 
of the two participants recruited for this thesis also recorded a slower time to completion at 
MTPOST. Two out of the ten participants’ time to completion scores improved by MTPOST, 
however this may simply be due to a learning process whereby the participants became more 
familiar with treadmill running, or running for a more consistent period of time.   
It is widely understood in elite sport that small worthwhile changes of 1% to physical 
performance capacity can be a decisive factor in determining competitive success (Whyte, 
2006). Cohen et al. (1988) claimed that an ES of 0.2 equates to a variance explained by 1%. 
In this present study, it was determined that a small ES (d = 0.32) was observed between the 
mean time to completion scores at MTPRE and MTPOST. This suggests that the decreased 
physical performance capacity at MTPOST in the seven participants would have significantly 
compromised competitive success. To put the 01:11 mean difference in completion time into 
perspective, such a time difference during the 2012 10 km final at the Rio de Janeiro Olympics 
would have separated 1st place with 32nd place (Olympic, 2016). A decreased physical 
performance capacity following the ITP may have resulted from the development of more 
severe headaches which may have impaired cognitive function that further impacted work 
capacity (Martins de Araújo et al., 2012). This relationship however was only found in two 
(participant one and seven) out of the ten participants. Alternatively, elevated levels of sport-
related stress, in particular a heightened perception of muscular discomfort and injury, may 
have negatively impacted participants’ ability to complete the TT. A clear example of this can 
be observed in participant two, their ‘general stress’ scores from the RESTQ 76 Sport 
Questionnaire increased from 5.4 to 7 MTPOST. This increase in perceived stress following the 
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ITP was coupled with a significantly longer time to completion score, which increased from 
44:59 at MTPRE to 53:13 at MTPOST. This trend was similarly observed in three other participants 
(participant three, seven, and ten).  
A decrease to TT performance following a similar period of intensified training has previously 
been reported by Jeukendrup et al. (1992) and Halson et al. (2002). These studies 
demonstrated that a 2-week period of intensified training completed by 7 competitive cyclists 
and 8 endurance cyclists, respectively, resulted in a significant increase in time to completion 
in response to a simulated TT event. Both Jeukendrup et al. (1992) and Halson et al. (2002) 
reported that this reported decrease in TT performance was indicative that participants had 
become overreached. If true, then this may suggest that seven out of the nine recorded 
participants may have become overreached following the ITP.  
Upper-respiratory Tract Symptoms 
An increased susceptibility to URTS is often reported by athletes who have developed NFOR 
or the OTS (Fry et al., 1991; Robson-Ansley and Costa, 2014).  Following the ITP, six out of 
the ten participants had developed more severe URTS. In contrast, the two participants who 
were recruited for this thesis did not develop any URTS by MTPOST. The difference in results 
may be explained by the seasonal variations between the two cohorts. The eight previous 
participants primarily undertook this study design during autumn and winter where the 
incidence of URTS development is far greater in individuals (Atkinson and Drust, 2005). 
Contrary to this, the two participants who were recruited for this particular thesis undertook 
this study design during spring and summer where the risk of URTS development is much less 
(Atkinson and Drust, 2005). This is a clear limitation to the study, however due to the time 
restrictions enforced during the Masters by Research degree, it was unpreventable as data 
collection could only begin in early spring.  
After further investigation into which particular URTS had increased in the six participants, it 
was apparent that the ‘headache’ subscale had significantly elevated by MTPOST. Large ES 
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between malaise, nasal obstruction, joint aches and pain and nasal discharge score were also 
reported between MTPRE and MTPOST. It has been proposed that the increased susceptibility 
to URTS following intensified training is caused by impaired immune function (Peters and 
Bateman, 1983; Neiman et al., 1990; Verde et al., 1992; Gomez-Merino et al. 2005; Morgado 
et al., 2012). This could therefore imply that the six participants had developed possible 
immune impairment(s) by the end of the ITP that permitted the development and increased 
severity of URTS. 
Collectively, only one participant (participant eight) exhibited all of the measured symptoms of 
NFOR/OTS following the ITP, however as highlighted by Meeusen et al. (2012), symptoms of 
overtraining will vary from individual to individual and that all of the reported symptoms may 
not be exhibited all at the same time. All of the participants in this study however had reported 
at least one symptom of NFOR/OTS following the ITP which is suggestive that it was likely all 
ten participant were close to developing, or had fully developed a state of overreaching. This 
present study was unable to truly determine whether participants were overreached as it did 
not retrospectively measure the time it took participants to recover and for their symptoms to 
return to baseline following MTPOST. This would have meant implementing more TT’s  following 
the ITP which could have proved unethical considering the vast difficulty and longevity of the 
initial study design.  
6.2 Aetiology of Upper-respiratory Tract Symptoms 
The significant development of headaches reported at MTPOST may have occurred due to the 
onset of dehydration (Blau et al., 2004), however no changes in hydration status was observed 
over the ITP. Alternatively, the reported increased general- and sport-related stress scores 
may indicate that the accumulation of training and/or non-training stress could have triggered 
the development of headaches (Theeler et al. 2010).  
It is unlikely that the developed URTS reported by six participants was caused by the infiltration 
of foreign infectious or non-infectious antigens into the body. If infectious, allergenic, or 
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pollutant antigens were present at the time of blood extraction, then it would have markedly 
elevated the pre RPETR (resting) blood PMN concentration at MTPOST as exposure to such 
antigens during the ITP would have induced  a resting state of neutrophilia (Dias et al., 2011; 
Xu et al., 2013; Hosoki et al., 2015). Furthermore, there were no significant changes to TNF-
α and IL-8 concentrations that were produced by non-stimulated PMN over the ITP. The 
production of pro-inflammatory cytokines from non-stimulated PMN may have reflected 
whether PMN were stimulated by the presence of PAMP in vivo prior to harvest. Overall, the 
production of IL-8 by non-stimulated PMN was generally higher in comparison to the IL-8 
production by antigen-stimulated PMN which may imply that PMN were stimulated whilst they 
were still circulating within the blood. In contrast, the production of TNF-α by non-stimulated 
PMN was low throughout the training period. A low production of TNF-α would have not 
occurred if antigens were present within the blood stream as it has been demonstrated that 
antigen-stimulated PMN will produce significant concentrations of TNF-α. The reported high 
level of IL-8 production from non-stimulated PMN may have therefore occurred due to 
incorrect handling techniques during the completion of the ELISA or during the initial harvest 
of PMN which could have caused the PMN to undergo necrosis. Alternatively, the lack of 
stimulation in vitro whilst performing the isolation and washing procedures may have caused 
PMN to undergo apoptosis as a regulatory mechanism to prevent the cytotoxic nature of 
inactivated PMN from harming healthy tissue (Nathan, 2002).  It is understood that PMN can 
store pre-formed IL-8 within cytoplasmic bound vacuoles (Pellmé et al., 2006). If PMN 
therefore became necrotic or underwent apoptosis, then this could have released these 
vacuoles containing IL-8 into the culture medium. Nevertheless, it appears that the aetiology 
of URTS in this present study is unknown and could ultimately only be determined through 
invasive methods of which this research project was unable to use. 
6.3 Blood Neutrophil Count 
In this present study, neutrophilia was evident following the RPETR at MTPRE and MTPOST in  the 
two participants specifically recruited for this thesis and also in the ten combined participants. 
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Resting or exercise-induced blood PMN concentrations at MTPRE and MTPOST however were 
not significantly different. Neutrophilia in response to a high-intensity exercise bout alike the 
RPETR has previously been reported by Field et al. (1991), Neiman et al. (1994) and Quindry 
et al. (2003) and is thought to be provoked by an elevation in glucocorticoids such as cortisol, 
and cytokines such as granulocyte-macrophage colony-stimulating factor, TNF-α and 
leukotriene B4. These stimulants have been reported to downregulate the expression of ICAM 
upon endothelial cells, thus preventing PMN migration into tissue (Griffin et al., 1990). This 
present study established that TNF-α production by antigen-stimulated PMN will increase over 
the course of a high-intensity exercise bout such as the RPETR. This elevated TNF-α 
production by antigen-stimulated PMN may therefore partially account for the exercise-
induced neutrophilia by downregulating ICAM upon endothelial cells and thus limiting PMN 
mobilization during exercise. Alternatively, the reported neutrophilia could be due to an 
elevated production of cortisol that similarly downregulated participants’ ICAM upon their 
endothelial cells. No measure of cortisol was completed during this present research, however 
the cortisol concentrations of eight participants used within this study was measured within 
the preceding study by Leal (2017; unpublished) who reported that both salivary and plasma 
cortisol concentrations did not alter over the RPETR.. This suggests that TNF-α release from 
activated PMN within the blood stream may potentially be an important mechanism that 
influences neutrophilia during exercise in the absence of elevated cortisol production. Further 
research could investigate whether glucocorticoid receptor knockout mice may display similar 
levels of neutrophilia during exercise compared to a control group. This may emphasize the 
effectiveness of cytokines such as TNF-α and other mechanisms in the appearance of 
neutrophilia within the blood during exercise.  
It must also be highlighted that during the harvesting of PMN from the isolation medium post-
centrifuge, there may have been contamination from other granulocytes such as basophils 
and eosinophils which could have been present within the harvested granulocyte band.  As 
these cell types have been reported to rise in response to a 6-minute cycle ergometer test 
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(Schwindt et al., 2007), then such cells may have accounted for the reported exercise-induced 
neutrophilia. While possible, it is unlikely that sufficient numbers of eosinophils and basophils, 
which have a comparatively lower concentration within the blood than PMN (Abbas et al., 
2014), could account for this neutrophilia.  
Previous research by Robson-Ansley et al. (2007) has similarly reported no changes to resting 
blood PMN concentration following a 12-day ITP. In contrast, Svendsen et al. (2016) and 
Hooper et al. (1995) reported a decreased resting blood PMN concentration following an 8-
day ITP and a 6-month competition period, respectively. It was proposed by both authors that 
this reduction in resting blood PMN concentration was caused by the development of chronic 
inflammation within skeletal tissue resulting from prolonged exercise with limited recovery. A 
hallmark sign of chronic inflammation is the shift from short-lived PMN to longer-lasting 
macrophages and lymphocytes (Allison et al., 1978). The onset of chronic inflammation may 
ultimately lead to a shift in the type of leukocyte present within the inflamed tissue, thus 
reducing circulating PMN concentration and subsequently increasing lymphocyte and 
macrophage concentration. The finding that resting PMN concentration did not change 
following the ITP within this present study may therefore suggest that any inflammation 
developed over the ITP was acute in nature and did not progress into a chronic state.  
6.4 Pro-inflammatory Cytokine Production by Antigen-stimulated Neutrophils in 
Response to the RPETR 
This present study reports that  an acute bout of short-duration, high-intensity exercise such 
as the RPETR can significantly elevate TNF-α and IL-8 production by antigen-stimulated PMN, 
thus upregulating a greater inflammatory response to exercise. TNF-α is an important 
mediator of the immediate inflammatory response by initiating the mobilization of phagocytes 
into compromised tissue (Walsh, 2013), increasing the release of cytokines from cells such as 
IL-1, IL-6, IL-8 and colony-stimulating factors (Walsh, 2013), promoting vasodilation (Johns 
and Webb, 1998) and increasing endothelial permeability (Hoffman et al., 2002). Alternatively, 
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IL-8 is another important inflammatory mediator by attracting leukocytes such as T cells,  
basophils and PMN into tissue, upregulating ICAM on endothelial cells to promote a greater 
transmigration of leukocytes (Bickel, 1993), stimulating histamine release (Koch et al., 1992) 
and increasing angiogenesis (Koch et al., 1992). 
An increased inflammatory response during and following exercise may be useful in clearing 
foreign antigens that have been inhaled through the mouth or nose due to a greater exercise-
induced respiratory rate (Burton et al., 2004). Additionally it may also emphasize the recovery 
process of exercise-induced skeletal tissue microtrauma (Coico, 2015). A heightened 
inflammatory response during or following exercise may however have negative implications 
to an individual’s health if left untreated. The accumulation of exercise-induced microtrauma 
has been theorised to lead to the onset of acute systemic inflammation which can cross-talk 
with the brain to develop sickness behaviours (Smith, 2000). Sickness behaviours such as a 
loss of appetite, increased fatigue, increased sensitivity to pain, and a loss of motivation are 
symptoms associated with states of NFOR and the OTS (Fry et al., 1991). Pro-inflammatory 
cytokine production may therefore be implicated in the development of sickness behaviours 
associated with NFOR and the OTS. As presented within the literature review, considering 
PMN are the primary leukocyte mobilized during the immediate inflammatory response,  an 
exercise-induced increase in pro-inflammatory cytokine production by antigen-stimulated 
PMN may, over periods of continuous exercise training, mediate the activation of blood-brain 
mechanisms which leads to the development of  the sickness behaviours  that are often 
reported by athletes who have developed NFOR or the OTS.  
An increased perception of stress was evident at MTPOST which implied the potential 
development of sickness behaviours. Further investigation of the RESTQ 76 Sport 
Questionnaire shown that participants also developed minor (P > 0.05) psychological and 
behavioural impairments such as a heightened perception of general, social, and emotional 
stress, a lack of energy, a decreased sleep quality, increased sensation of burnout, and lower 
self-regulation and efficiency. It could therefore be theorised that the reoccurring exercise-
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induced rises in pro-inflammatory cytokine production from stimulated PMN over the ITP 
initiated cross-talk with the central nervous system that contributed to the development of 
minor psychological and behavioural impairments that were present at MTPOST.  
The development of acute systemic inflammation due to elevated pro-inflammatory cytokine 
production by PMN may trigger a corresponding rise in anti-inflammatory cytokines such as 
IL-10 (Opal and DePalo, 2000). Anti-inflammatory cytokines such as IL-10 are the primary 
inhibitors of the inflammatory response within the body and have subsequently been reported 
to inhibit pro-inflammatory cytokine production by PMN (Wang et al., 1994). Inhibition of pro-
inflammatory cytokine production by PMN may lead to a greater susceptibility of URTS by 
reducing the inflammatory responses ability to clear antigen challenge from the body. As 
presented, pro-inflammatory cytokine production by antigen-stimulated PMN increased in 
response to the RPETR. Hypothetically, repeated production of pro-inflammatory cytokines by 
antigen-stimulated PMN over an ITP may lead to a concurrent increase in anti-inflammatory 
cytokines such as IL-10 that effectively inhibits pro-inflammatory production by PMN – of which 
this thesis has demonstrated following the ITP.  
The reported neutrophilia following the RPETR may have been responsible for the rise in TNF-
α and IL-8 concentrations by antigen-stimulated PMN. An increased number of circulating 
PMN post RPETR mean that there would have been more cells harvested and activated by  
LPS in vitro, thus potentially constituting to a greater TNF-α and IL-8 concentration following 
exercise. Furthermore, as previously stated, harvested PMN may have been contaminated 
with a small number of basophils and eosinophils. It has previously been reported that 
eosinophils are able to produce TNF-α when activated by antigen challenge (Finotto et al., 
1994). The exercise-induced rise in TNF-α concentration by antigen-stimulated PMN could 
therefore have been caused in part by the rise and activation of eosinophils. Neither basophils 
or eosinophils however have been reported to produce IL-8, which may indicate that the rises 
in pro-inflammatory cytokine production derived solely from PMN. Additionally, eosinophils 
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and basophils are minority cell types in blood and not mobilised in large numbers during 
exercise.  
The increased production of TNF-α and IL-8 by antigen-stimulated PMN after the RPETR may 
also be as a result of TLR4 upregulation upon PMN. It has been reported that acute bouts of 
moderate-to-high intensity aerobic exercise such as the RPETR can increase the mRNA 
expression and protein level of TLR4 upon cells such as monocytes, PMN, endothelial cells 
and adipose tissue (Booth et al., 2004; Rosa et al., 2011; Zbinden-Foncea et al., 2012; 
Rodriguez-Miguelez et al., 2015). PMN can express cytokines following the ligand-receptor 
interaction with TLR4 which activates the transcription factor NF-kB (Kawait and Akira, 2010) 
to transport to the cell nucleus where it triggers the expression of cytokines (Means et al., 
2000). The RPETR performed during this study may have increased the expression of TLR4  
on PMN which in turn permitted a greater expression of TNF-α and IL-8 by PMN when 
stimulated by LPS in vitro.  
6.5 Pro-inflammatory Cytokine Production by Antigen-stimulated Neutrophils 
Following 12-days of Intensified Training 
A reduced exercise-induced increase in TNF-α and IL-8 production by antigen-stimulated 
PMN was observed at MTPOST in both the two participants recruited specifically for this thesis 
and also in the ten combined participants. These findings were not statistically significant, 
however a large ES was found between the mean exercise-induced change reported at MTPRE 
and MTPOST which indicates that the reduced exercise-induced increase at MTPOST is still a 
significant finding and worthy of investigation. 
Previous research suggests that athletes with NFOR or the OTS report of an increased 
susceptibility to URTS (Heath et al., 1992; Nieman, 1994; Pyne and Gleeson, 1998; Tiollier et 
al., 2005; Gleeson, 2006a; Neville et al., 2008; Hausswirth et al., 2014). The greater 
susceptibility to URTS is associated with several immune impairments that have been reported 
occur following periods of intensified training (Peters and Bateman, 1983; Neiman et al., 1990; 
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Verde et al., 1992; Gomez-Merino et al. 2005; Morgado et al., 2012). It is yet to be concluded 
however which particular immune impairment, or the effect of multiple impairments, may lead 
to the pathogenesis of reported URTS. 
This present study reports that after a period of intensified training, a lower pro-inflammatory 
response by antigen-stimulated PMN is evident following the completion of exercise such as 
the RPETR. A reduced inflammatory response by antigen-stimulated PMN following exercise 
should hypothetically impair the clearance of foreign antigens from the body that may become 
prevalent during exercise. An impaired clearance of antigens within the body may 
subsequently manifest and could lead to the development of URTS. It is particularly important 
that there is an adequate inflammatory response during exercise as the risk of exposure to 
foreign antigens may be particularly higher due to the increased exercise-induced respiratory 
rate that permits a greater inhalation through the mouth and nose (Burton et al., 2004). 
Therefore, a reduced pro-inflammatory response by PMN during exercise may be significantly 
detrimental to athletes, particularly to those who are performing in potentially noxious 
environments such as highly polluted areas which are becoming increasingly more common. 
A reduction to pro-inflammatory cytokine production by antigen-stimulated PMN may therefore 
be one of several dysregulated immune functions responsible for the development of URTS 
in NFOR/OTS athletes.   
A reduced pro-inflammatory cytokine production by a leukocyte has similarly been reported 
by Morgado et al. (2012) who observed a reduced pro-inflammatory cytokine response (IL-1, 
IL-6, IL-12, TNF-α, and MIP-1) from dendritic cells and monocytes following a 6-week increase 
to training load in elite swimmers. Interestingly, this reduction was also associated with greater 
episodes of URTS alike this present study, thus furthering the hypothesis that a reduced pro-
inflammatory cytokine production by particular leukocytes may be heavily responsible in the 
development of URTS in athletes. It is not fully understood what particular mechanisms 
caused this apparent reduction in pro-inflammatory cytokine production by antigen-stimulated 
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PMN (and other leukocytes in previous research), however the following hypotheses have 
been considered.   
It has been postulated that a decreased PMN function following an ITP may result from an 
influx of immature, sub-functional PMN into the circulation (Robson-Ansley et al., 2007). At 
MTPOST, there was a small raise (P > 0.05) in the resting and exercise-induced concentration 
of PMN in response to the RPETR compared to the concentrations measured at MTPRE. This 
finding may highlight that a greater number of immature PMN were being released from bone 
marrow reserves and into the periphery. Previous research conducted by Drifte et al. (2013) 
reported that immature PMN were less efficient at mediating important innate immune 
functions such as bacterial phagocytosis and killing via the production of reactive oxygen 
species.  A possible influx of immature PMN at MTPOST may therefore be inefficient at 
producing pro-inflammatory cytokines compared to the mature PMN that were potentially the 
more dominant cell-type present at the time of harvest during MTPRE. In addition, the cytokine 
IL-10 has been reported to inhibit pro-inflammatory cytokine production by PMN (Wang et al., 
1994). A bout of high-intensity cycling has been reported to significantly elevated plasma IL-
10 concentrations in healthy, physically active participants (Dorneles et al., 2016). The effect 
of cumulative exercise with repeated spikes in IL-10 production may therefore have inhibited 
IL-8 and TNF-α production from neutrophils. Unfortunately, no measure of plasma IL-10 was 
completed during this present study and therefore it is difficult to determine whether elevations 
in IL-10 were responsible for the inhibition.  
Whether or not reduced pro-inflammatory cytokine production by antigen-stimulated PMN 
during exercise is capable of increasing the susceptibility of URTS is undetermined. In theory, 
a significant decrease in pro-inflammatory cytokine production by antigen-stimulated PMN 
following exercise may perhaps indicate that PMN are less responsive in mediating the 
immediate inflammatory response against foreign or self-antigens that may become prevalent 
during exercise, thus increasing the risk of infection or cellular damage. This vulnerability 
however may only occur when pro-inflammatory cytokine production by stimulated PMN falls 
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below a certain threshold. Even so, the immune system boasts an impressive armoury of 
functions to rid antigen challenge from the body even if TNF-α and IL-8 production from 
stimulated PMN is compromised. TNF-α can otherwise be produced by monocytes, T cells 
and natural killer cells (Walsh, 2013) whereas IL-8 can be produced by epithelial cells, 
fibroblasts, endothelial cells, macrophages, lymphocytes, and mast cells (Bickel, 1998). 
Nevertheless, as PMN are the first (before macrophages, lymphocytes, and mast cells) and 
most abundant leukocyte mobilized during the immediate inflammatory response (Freire and 
Van Dyke, 2013), their ability to produce pro-inflammatory cytokines may significantly 
compromise the subsequent mobilization and activation of leukocytes to produce more pro-
inflammatory cytokines to evoke an adequate inflammatory response against antigen 
challenge. This apparent reduced exercise-induced increase in pro-inflammatory cytokine 
production by antigen-stimulated PMN after a period of intensified training may ultimately 
mediate a less effective inflammatory response against antigen challenge which could be one 
of several immune impairments responsible for the pathogenesis of reported URTS in 
NFOR/OTS athletes.  
The reduced exercise-induced increase of pro-inflammatory cytokine production by antigen-
stimulated PMN also emphasizes that it may perhaps not only be the PMN microbicidal 
function which decreases following a period of intensified training, but also PMN ability to 
mediate an inflammatory response against antigen challenge. This present study therefore 
emphasizes that if PMN function was to be used as a sensitive biological marker to detect the 
onset of NFOR or the OTS, as suggested by Gleeson et al. (2002) and Yaegaki et al. (2008), 
then a comprehensive overview of all of its functions could be used.  
6.6 Future Research Considerations 
In light of the findings from this present study, many questions which have been left unresolved 
could be addressed in future research. To understand the mechanisms that regulate exercise-
induced neutrophilia, future research may want to consider the role of TNF-α produced by 
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PMN in regulating ICAM expression. To determine the mechanisms that are responsible for 
the altered pro-inflammatory cytokine response by PMN following an ITP, future research 
could determine whether a concurrent rise in the production of IL-10 over an ITP is associated 
with the decline in PMN function. In addition, future research may also want to determine 
whether immature or sub-functional PMN are less responsive to antigen challenge compared 
to mature functional PMN.  As presented, TLR4 upregulation may be responsible for the 
increased production of pro-inflammatory cytokines by antigen-stimulated PMN following a 
bout of high-intensity exercise. Future research could use flow cytometry or quantitative 
polymerase chain reaction (qPCR) analysis to determine whether TLR4 is upregulated on 
PMN following a bout of high-intensity exercise.  
6.7 Conclusion 
In conclusion, a 12-day ITP reduced exercise-induced pro-inflammatory cytokine production 
by antigen-stimulated PMN. As a decreased pro-inflammatory cytokine production may impact 
the body’s ability to successfully clear antigen challenge, this finding may be one of several 
immune impairments that could lead to the pathogenesis of reported URTS in NFOR and OTS 
athletes.  
6.8 Limitations 
The following limitations were present during this study: 
1. High intra-assay coefficient of variance values from the TNF-α ELISA tests would have 
produced less accurate concentrations, therefore the absolute rise in antigen-
stimulated TNF-α concentrations could have been statistically significant between 
MTPRE and MTPOST.   
2. The harvesting of PMN using the Lympholyte-polyTM method may have been 
contaminated by a small number of basophils and eosinophils which may have 
contributed to the total blood PMN counts. Purification of PMN using flow cytometry or 
magnetic bead-based cell sorting could have prevented this.   
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3. 25 samples violated the standard curve of the TNF-α or IL-8 ELISA tests. The optical 
densities of these samples were consequently extrapolated which could make the 
concentration of these samples less accurate.   
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Chapter 8. Appendices 
8.1 Ethical Approval Document 
 
 
 
 
130 
 
8.2 Participant Information Sheet 
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8.3 Consent Form 
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8.4 Health Screen and Physiological Questionnaire  
 
Name/Student Number ...............…….  
Sex:...............……. 
Date of Birth ...............……. 
Health Screen and Physiological Testing Questionnaire 
 
As an individual participating in physical activity, it is important that you are currently in good 
health. This is to ensure your well-being and to try and prevent confounding data. This 
completed questionnaire will be held in a locked filing cabinet in the Sport and Exercise 
Science Laboratories for a period of three years. After this time it will be shredded. Please 
ask for a photocopy of this questionnaire if you require one. 
 
Please complete this brief questionnaire to confirm your ability to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise ............ Yes 
 
No  
(b) attending your general practitioner ................... Yes  No  
(c) on a hospital waiting list for an injury ................ Yes  No  
(d) recovering from an illness or operation ............. Yes  No  
 
2. In the past two years, have you had any illness or injury which required you to: 
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(a) consult your GP ................................................ Yes 
 
No  
(b) attend a hospital outpatient department ........... Yes  No  
(c) be admitted to hospital  .................................... Yes  No  
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy  ........................................ Yes 
 
No  
(b)         Respiratory conditions such as 
asthma/bronchitis/ Turburculosis……………….. 
Yes 
 
No  
(d) Eczema  ............................................................ Yes  No  
(e) Diabetes  ........................................................... Yes  No  
(f) A blood disorder (including infections/viruses) ... Yes  No  
(g) Head injury including concussion ...................... Yes  No  
(h) Digestive/ Gastrointestinal problems  ................ Yes  No  
(i) Heart problems/chest pains/ angina/heart 
attack/varicose vein/ 
embolism/aneurysm.……………………………. 
Yes  No  
(j) Problems with muscles, bones or joints (for 
example arthritis/back pain) ............................... 
Yes  No  
(k) Disturbance of balance/coordination  ................ Yes  No  
(l) Dizziness / black outs / fainting ......................... Yes  No  
(m) Disturbance of vision  ........................................ Yes  No  
(n) Ear/hearing problems  ....................................... Yes  No  
(o) Thyroid problems  ............................................. Yes  No  
(p) Kidney or liver problems  ................................... Yes  No  
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(q) Problems with blood pressure (low or high) ....... Yes  No  
(r)  A pacemaker  .................................................... Yes  No  
(s) Chronic obstructive pulmonary disease 
(COPD) 
Yes  No  
 
(t) Anaphylactic shock symptoms to needles, 
probes or other medical-type equipment 
Yes  No  
(u)  Any allergies or food intolerances Yes  No  
(v)  A history of heart disease in the family Yes  No  
(w)  Been pregnant or given birth in the last 6 
months 
Yes  No  
(x) Rectal problems Yes  No  
 
If YES to any question, please describe in more detail if you wish (for example, was the 
problem short lived, if it is controlled, if it is re-occurring, if your doctor has given you specific 
information/instructions regarding the problem).  
 
...................................................................................................................................................
...................................................................................................................................................
........................ 
 
4. Please state what medication (if any) you are currently taking, explain briefly what the 
medication is for and how long you have been taking it. 
 
…………………………………………………………………………………………………………………… 
 
5.  Do you have any other condition or disability that you feel we should be aware of? 
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Yes 
 
                                   No  
 
If yes, please briefly explain below: 
 
…………………………………………………………………………………………………………………… 
 
6. Are you currently involved in any other lab activity at the University or elsewhere? 
 Yes  No  
If yes, please provide details.  
 
……………………………………………………………………………………………………………
… 
 
7. Please provide contact details of a suitable person for us to contact in the event of any incident 
or emergency. 
 
Name:       Relationship to Participant: 
          ……………………………………………                                      ………………………… 
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Telephone Number:  Work  Home  Mobile ……………………………… 
 
 
 
 
 
 
 
 
 
 
 
 
 
I declare that this information is correct, and is for the sole purpose of giving the tester guidance 
as to my suitability for the test. 
As far as I am aware, there is nothing that might prevent me from successfully completing the 
tests that have been outlined to me. For any issues raised in sections 1-5 the appropriate 
precautions (Doctors check, medication to hand) have been taken and I am therefore still willing 
and able to participate in the current laboratory session as a participant. Whilst also being aware 
of the risks associated with the current protocol.  
 
Signed (student) ………………………………………………  Date………………………….. 
 
Signed (Session leader) ………………………………………  Date………………………….. 
 
If there is any change in the circumstances outlined above, it is your responsibility to tell the 
person administering the test immediately.  
143 
 
8.5 Jackson Upper-Respiratory Tract Symptom Questionnaire  
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8.6 RESTQ 76 Sport Questionnaire  
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8.7 Training Diary  
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8.8 Food Diary 
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8.9 Main Trial Data Sheet 
 
